 |
- Condition: Cow Milk Allergy
Intervention: Diagnostic Test: COMISS score
Sponsor: caroline maher
Not yet recruiting - Conditions: Eczema; Asthma; Allergy;Food
Intervention: Drug: EpiCeram
Sponsor: University of Melbourne
Recruiting - Conditions: Preterm Infant; Mothers; Parent-Child Relations; Child Development; Interaction, Mother-Infant
Intervention: Other: GP_Posit
Sponsor: St. Justine's Hospital
Not yet recruiting - Condition: Cow Milk Allergy
Intervention: Other: Food for Specific Medical Purpose
Sponsor: Nestlé
Not yet recruiting - Conditions: Obesity; Taste Sensitivity
Intervention: Other: No Intervention
Sponsor: St Mary's University College
Recruiting - Conditions: Myocardial Insulin Sensitivity; Impaired Glucose Metabolism; Diastolic Dysfunction
Interventions: Drug: Ciprofibrate 100Mg Tablet; Drug: Placebo Oral Tablet
Sponsors: Maastricht University Medical Center; Maastricht University
Not yet recruiting - Condition: Hearing Loss, Sensorineural
Intervention: Other: Signal processing to improve intelligibility
Sponsors: University of Rochester; National Institute on Deafness and Other Communication Disorders (NIDCD)
Not yet recruiting - Condition: Ovarian Cancer Recurrent
Interventions: Biological: DCVAC/OvCa; Drug: Standard of Care Chemotherapy
Sponsor: Sotio a.s.
Recruiting - Condition: Peanut Allergy
Intervention: Other: Peanut oral immunotherapy
Sponsors: Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research, United Kingdom; King's College London; Imperial College London
Recruiting - Condition: Allergy to Arthropod Sting
Intervention: Diagnostic Test: Local insect allergen extracts skin test
Sponsor: Mahidol University
Recruiting - Condition: Food Allergy
Intervention: Diagnostic Test: skin test with food at different storage times
Sponsor: Mahidol University
Recruiting - Condition: Cow Milk Allergy
Intervention: Other: Oral Immunotherapy
Sponsor: McGill University Health Center
Recruiting - Conditions: Pain; Physical Activity
Interventions: Other: Hypoalgesia expectation; Other: Hyperalgesia expectation; Other: Neutral
Sponsors: Odense University Hospital; University of Southern Denmark
Recruiting - Conditions: Type 2 Diabetes Mellitus; PreDiabetes
Intervention: Drug: Sitagliptin
Sponsor: National University of Malaysia
Recruiting - Condition: Delayed Type Hypersensitivity
Interventions: Drug: Prednisone; Drug: Placebo
Sponsor: Innovaderm Research Inc.
Recruiting - Condition: Allergic Rhinitis
Intervention: Other: e-BOOK
Sponsor: Assistance Publique Hopitaux De Marseille
Not yet recruiting - Condition: Skin Care
Interventions: Other: Developmental Serum; Other: Physiogel Calming Relief Anti-Redness Serum
Sponsor: GlaxoSmithKline
Not yet recruiting - Condition: Metabolic Syndrome
Interventions: Drug: Amla; Drug: Placebo
Sponsor: University of Guadalajara
Not yet recruiting - Condition: Allergic Rhinitis Due to Animal Hair and Dander
Intervention: Diagnostic Test: rat and mouse skin test
Sponsor: Mahidol University
Recruiting - Conditions: Myocardial Infarction; Chest Pain
Intervention:
Sponsors: Aarhus University Hospital; Randers Regional Hospital
Recruiting - Conditions: Myocardial Infarction; Myocardial Injury
Intervention:
Sponsor: University Hospital Southampton NHS Foundation Trust
Not yet recruiting - Condition: Pain
Intervention:
Sponsor: Istanbul Medeniyet University
Recruiting - Condition: Multiple Sclerosis
Interventions: Diagnostic Test: MEP using standard facilitation technique; Diagnostic Test: MEP using modified facilitation technique
Sponsor: University Hospital, Basel, Switzerland
Recruiting - Condition: Metabolic Syndrome
Interventions: Drug: Fucoxanthin; Drug: Magnesium Sterate
Sponsor: University of Guadalajara
Not yet recruiting - Condition: Hypersensitivity Reactions
Intervention: Drug: Dexamethasone
Sponsor: Loma Linda University
Not yet recruiting - Condition: Asthma
Interventions: Drug: Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals; Drug: ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK; Drug: Placebo
Sponsor: Respirent Pharmaceuticals Co Ltd.
Not yet recruiting - Condition: Caries Class Ii
Interventions: Other: Nano Care Gold; Other: No intervention; Other: Chlorhexidine
Sponsor: Cairo University
Not yet recruiting - Condition: Asthma in Children
Intervention: Drug: Soluble Corn Fiber
Sponsors: Phoenix Children's Hospital; Northern Arizona University; Flinn Foundation; Mayo Clinic
Not yet recruiting - Conditions: Eosinophilic Gastritis; Eosinophilic Gastroenteritis
Intervention: Drug: Dupilumab
Sponsors: Children's Hospital Medical Center, Cincinnati; Regeneron Pharmaceuticals
Not yet recruiting - Condition: Contrast Medium
Intervention: Drug: Iopromide (Ultravist, BAY86-4877)
Sponsor: Bayer
Not yet recruiting - Condition: Allergic Conjunctivitis
Interventions: Drug: Reproxalap Ophthalmic Solution (0.25%); Drug: Reproxalap Ophthalmic Solution (0.5%); Drug: Vehicle Ophthalmic Solution
Sponsor: Aldeyra Therapeutics, Inc.
Not yet recruiting - Condition: Recurrent Ovarian Cancer
Interventions: Diagnostic Test: ChemoID assay; Drug: Chemotherapy
Sponsor: Cordgenics, LLC
Recruiting - Condition: Dermatitis, Atopic
Intervention: Device: BAY987534
Sponsor: Bayer
Not yet recruiting - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Dihydromyricetin; Drug: Metformin
Sponsor: University of Guadalajara
Not yet recruiting - Conditions: Asthma; Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases; Physiological Effects of Drugs
Interventions: Drug: Placebo; Drug: QAW039 Dose 1; Drug: QAW039 Dose 2
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - Conditions: Metal Allergy; Contact Allergy; Restenoses, Coronary; In-stent Restenosis; Coronary Artery Disease
Intervention: Biological: In-stent restenosis
Sponsor: Silesian Centre for Heart Diseases
Not yet recruiting - Condition: Rhinitis Seasonal
Interventions: Drug: Fexofenadine M016455; Drug: Placebo
Sponsor: Sanofi
Not yet recruiting - Conditions: Atopic Dermatitis; Atopic Dermatitis Eczema
Intervention: Drug: Dupilumab
Sponsors: University of California, San Francisco; Regeneron Pharmaceuticals
Not yet recruiting - Condition: Eosinophilic Gastritis
Intervention: Drug: AK002
Sponsor: Allakos, Inc.
Not yet recruiting - Conditions: Dermatitis; Dermatitis, Atopic; Eczema; Skin Diseases; Skin Diseases, Genetic; Genetic Diseases, Inborn; Skin Diseases, Eczematous; Hypersensitivity; Hypersensitivity, Immediate; Immune System Diseases
Interventions: Drug: PF-04965842 100 mg; Drug: PF-04965842 200 mg; Drug: Placebo
Sponsor: Pfizer
Recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: EpiCeram; Drug: Aveeno Daily Moisturising Sheer Hydration Lotion®
Sponsor: Stanford University
Not yet recruiting - Condition: Allergy Drug
Interventions: Diagnostic Test: Allergy work-up; Other: Blood samples and microbiological samples.
Sponsor: Oslo University Hospital
Recruiting - Condition: Chest Pain
Intervention: Other: no intervention
Sponsors: Aintree University Hospitals NHS Foundation Trust; Royal Liverpool University Hospital; University of Liverpool
Recruiting - Condition: Nerve Pain
Intervention:
Sponsor: Julia Finkel
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Upadacitinib; Drug: Placebo for upadacitinib; Drug: Topical Corticosteroids (TCS)
Sponsor: AbbVie
Not yet recruiting - Conditions: Atopic Dermatitis; Alopecia; Hidradenitis Suppurativa; Vitiligo; Psoriasis
Intervention:
Sponsor: Target PharmaSolutions, Inc.
Not yet recruiting - Conditions: Celiac Disease; Celiac; Intestinal Disease; Malabsorption Syndromes; Gastrointestinal Disease; Digestive System Disease; Gluten Sensitivity; Autoimmune Diseases
Interventions: Biological: Nexvax2; Biological: Placebo
Sponsor: ImmusanT, Inc.
Recruiting - Conditions: Stevens-Johnson Syndrome; Lyell Syndrome; Drug Reactions; AGEP; DRESS; Bullous Dermatosis Caused by Drug Treatment (Disorder); Maculopapular Exanthem; Erythema Multiforme
Intervention:
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting - Conditions: Adverse Drug Event; Adverse Drug Reactions; Anaphylactic Reaction; Severe Adverse Reactions
Intervention: Drug: Xueshuantong-Injection
Sponsor: Zhong Wang
Not yet recruiting - Condition: Eosinophilic Esophagitis
Interventions: Other: 4FED; Other: 4FED+FREE
Sponsor: Nemours Children's Clinic
Not yet recruiting - Conditions: Asthma; Allergic Rhinitis; Allergic Conjunctivitis
Interventions: Other: Active air purifier in respiratory allergies/asthma; Other: Sham air purifier
Sponsor: Molekule
Recruiting - Conditions: EoE; Eosinophilic Esophagitis
Interventions: Drug: Mepolizumab 300 mg; Drug: Mepolizumab 100 mg; Other: Placebo
Sponsors: University of North Carolina, Chapel Hill; GlaxoSmithKline; University of Utah; Northwestern University; Minnesota Gastroenterology, P.A.
Not yet recruiting - Condition: HR+ HER2 Breast Cancer
Interventions: Drug: ribociclib; Drug: letrozole
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - Conditions: Allergic Asthma Due to Dermatophagoides Farinae; Allergic Asthma Due to Dermatophagoides Pteronyssinus; Allergic Rhinitis Due to House Dust Mite
Interventions: Biological: HDM SLIT-tablet; Other: Placebo
Sponsor: ALK-Abelló A/S
Recruiting - Condition: Atopic Dermatitis
Intervention: Drug: ASN002
Sponsor: Asana BioSciences
Not yet recruiting - Condition: Asthma
Interventions: Drug: TD-8236 (for SAD); Drug: TD-8236 (for MAD); Drug: Placebo (for SAD); Drug: Placebo (for MAD)
Sponsor: Theravance Biopharma
Not yet recruiting - Impact of Benralizumab Treatment on Circulating Dendritic Cells in Patients With Eosinophilic AsthmaCondition: Severe Eosinophilic Asthma
Intervention: Drug: Benralizumab
Sponsor: University of Rostock
Not yet recruiting - Condition: Asthma
Intervention: Drug: Fevipiprant
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - Condition: Asthma
Intervention: Other: Hailie Smart Inhaler electronic monitoring device
Sponsor: Connecticut Children's Medical Center
Recruiting - Condition: Asthma
Intervention: Behavioral: Technology Enabled Asthma Management System
Sponsors: University of Rochester; University of Rhode Island
Recruiting - Conditions: Appetitive Behavior; Individual Difference; Food Sensitivity; Food Preferences
Intervention: Behavioral: Expanded Corn Snack
Sponsors: University of Reading; University of Sussex; Quadram Institute; Unilever R&D; PepsiCo Global R&D; Mondelēz International, Inc.; Arla Foods; Mars, Inc.
Not yet recruiting - Conditions: Dyspepsia; Gastroparesis
Intervention: Device: taVNS
Sponsor: Massachusetts General Hospital
Not yet recruiting - Conditions: Polycystic Ovary Syndrome; Insulin Resistance; Vitamin D Deficiency; Obesity
Intervention:
Sponsors: St George's, University of London; SPD Development Company Limited
Not yet recruiting - Condition: Asthma in Children
Interventions: Other: PLTG; Other: Placebo
Sponsors: KK Women's and Children's Hospital; Singapore Thong Chai Medical Institution
Recruiting - Condition: Type 2 Diabetes Mellitus
Intervention: Other: Ischemic Preconditioning
Sponsors: Liverpool John Moores University; Aintree University Hospitals NHS Foundation Trust
Recruiting - Condition: Asthma
Interventions: Drug: Halix albuterol 90 mcg; Drug: albuterol HFA MDI 90 mcg
Sponsors: Concentrx Pharmaceuticals, Inc.; PharPoint Research, Inc.; Kramer Consulting LLC
Recruiting - Conditions: Allergic Rhinitis; Allergic Inflammation
Interventions: Diagnostic Test: Nasal Provocation with Birch Extract; Other: Nasal Provocation with NaCl 0.9%
Sponsor: Medical University of Vienna
Recruiting - Condition: Urticaria Chronic
Intervention: Biological: UB-221
Sponsor: United BioPharma
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Crisaborole; Drug: Tacrolimus 0.03% Ointment
Sponsor: University of Rochester
Not yet recruiting - Condition: Atopic Dermatitis
Intervention: Drug: Upadacitinib (ABT-494)
Sponsor: AbbVie
Not yet recruiting - Conditions: Asthma Acute; Asthma in Children; Asthma Chronic; Asthma Attack
Intervention:
Sponsor: University of California, San Francisco
Recruiting - Condition: ABPA
Intervention:
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Recruiting - Conditions: Obesity; Diabetes Mellitus, Type 2
Intervention: Other: High caloric diet
Sponsor: University Hospital Tuebingen
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Other: Endoscopy
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting - Condition: Henoch-Schönlein Purpura
Interventions: Drug: Methylprednisolone; Drug: IVIG; Procedure: blood purification
Sponsors: Children's Hospital of Fudan University; Shanghai Children's Hospital; Shanghai Children's Medical Center
Not yet recruiting - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Ovarian Neoplasms; Ovary Cancer; Fallopian Tube Neoplasms; Fallopian Tube Adenocarcinoma; High Grade Serous Carcinoma; Peritoneal Carcinoma; Peritoneal Neoplasms; Adnexal Mass; Ovarian Diseases
Intervention: Device: Hysteroscopic cell sampling of the fallopian tube
Sponsors: nVision Medical; Boston Scientific Corporation
Recruiting - Conditions: Sleep; Body Composition; Strength; Insulin Sensitivity; Energy Expenditure
Interventions: Dietary Supplement: Whey protein; Dietary Supplement: Omega-3 fatty acids
Sponsor: University of Arkansas, Fayetteville
Recruiting - Conditions: Asthma; Cough
Intervention: Device: The patient will undergo no intervention
Sponsors: Cantonal Hospital of St. Gallen; University of Zurich; University of St.Gallen
Recruiting - Conditions: Organoids; Rectal Cancer; Chemoradiation
Intervention: Other: Biopsy
Sponsor: Zhen Zhang
Recruiting - Condition: Hypersensitivity Dentin
Interventions: Procedure: Immediate dentin sealing protocol; Procedure: Delayed dentin sealing protocol
Sponsor: Cairo University
Not yet recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: Period 1 - Day 1: PF-04965842 administered; Drug: Period 2: Cohort 1: Fluvoxamine & PF-04965842; Drug: Period 2: Cohort 2: Fluconazole & PF-04965842
Sponsor: Pfizer
Not yet recruiting - Condition: Asthma
Interventions: Behavioral: Pulmonary rehabilitation; Other: Usual Care
Sponsor: NHS Greater Glasgow and Clyde
Recruiting - Condition: Eosinophilic Esophagitis
Interventions: Drug: Dupilumab; Drug: Placebo
Sponsors: Regeneron Pharmaceuticals; Sanofi
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Other: Ointment A; Other: Ointment B
Sponsor: BioGaia AB
Not yet recruiting - Conditions: Chest Pain; Coronary Artery Disease; Acute Coronary Syndrome; Ischemic Heart Disease
Intervention: Diagnostic Test: Cardiac CT angiogram
Sponsor: Guy's and St Thomas' NHS Foundation Trust
Recruiting - Condition: Cow Milk Allergy
Interventions: Dietary Supplement: rice formula; Dietary Supplement: placebo
Sponsors: United Pharmaceuticals; Statitec
Recruiting - Condition: Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB
Interventions: Drug: Telacebec (Q203); Drug: Rifafour e-275
Sponsor: Qurient Co., Ltd.
Recruiting - Condition: Spinal Stenosis Lumbar
Interventions: Drug: Pregabalin 75mg; Drug: Celebrex 200Mg Capsule
Sponsor: Seoul National University Bundang Hospital
Not yet recruiting - Conditions: Neuroendocrine Tumors; Insulinoma; Gastrinoma; Glucagonoma; Vipoma; Pheochromocytoma; Paraganglioma; Neuroblastoma; Ganglioneuroma; Medullary Carcinoma; Pituitary Adenoma; Medulloblastoma; Merkel Cell Carcinoma; Small-cell Lung Cancer; Meningioma; Carcinoid
Interventions: Diagnostic Test: 68Ga-DOTATOC PET/CT; Diagnostic Test: 18F-FDG PET/CT
Sponsor: British Columbia Cancer Agency
Recruiting - Conditions: Obesity; Severe Obesity; Sleep Apnoea
Interventions: Device: ECAL Indirect Calorimeter; Behavioral: Diet, exercise & behaviour modification therapy
Sponsors: University of Liverpool; Metabolic Health Solutions UK; Medtronic
Not yet recruiting - Condition: Dentinal Hypersensitivity
Interventions: Device: A.R.C. FOX Laser-FOX Q-810nm; Procedure: Control
Sponsor: National Taiwan University Hospital
Recruiting - Conditions: Asthma; Cough
Interventions: Other: Mannitol; Drug: Salbutamol 5mg/mL; Other: Sodium Chloride 0.9% Inhl 3Ml
Sponsors: McMaster University; Pharmaxis; AllerGen NCE Inc.
Not yet recruiting - Condition: Asthma
Intervention: Drug: Dupilumab SAR231893 (REGN668)
Sponsors: Sanofi; Regeneron Pharmaceuticals
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Antroquinonol; Other: Placebo
Sponsor: Golden Biotechnology Corporation
Recruiting - Conditions: Cystic Fibrosis; Asthma; Severe Persistent Asthma; Healthy
Intervention: Drug: Glycine Buffer
Sponsors: University Hospitals Cleveland Medical Center; National Institutes of Health (NIH)
Not yet recruiting - Condition: Moderate-to-severe Atopic Eczema
Intervention: Other: No study-specific intervention
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - Conditions: Eczema; Atopic Dermatitis; Atopic Dermatitis and Related Conditions
Interventions: Other: Bubbles; Other: Bleach and Bubbles
Sponsor: University of North Carolina, Chapel Hill
Recruiting - Condition: Eosinophilic Esophagitis
Interventions: Diagnostic Test: Bone Mineral Density (DEXA) scan; Diagnostic Test: Vitamin D Measurement; Diagnostic Test: Height measurement; Other: Assessment of medication compliance
Sponsors: Arkansas Children's Hospital Research Institute; University of Arkansas
Not yet recruiting - Conditions: Hypersensitivity; Beta Lactam Adverse Reaction
Intervention:
Sponsor: Nantes University Hospital
Not yet recruiting - Condition: Asthma
Intervention: Device: Video games
Sponsors: St. Justine's Hospital; Canadian Institutes of Health Research (CIHR); Concordia University
Not yet recruiting - Conditions: Asthma; Asthma in Children
Intervention: Device: BreatheSuite
Sponsor: Memorial University of Newfoundland
Not yet recruiting - Condition: Peanut Allergy
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network (ITN)
Recruiting - Conditions: Chest Pain; Acute Coronary Syndrome; Heart Attack
Intervention:
Sponsors: Manchester University NHS Foundation Trust; National Institute for Health Research, United Kingdom; Abbott Point of Care; LumiraDx; Roche Diagnostics
Not yet recruiting - Condition: Ovarian Carcinoma
Interventions: Drug: pegylated liposomal doxorubicin (PLD) + carboplatin (CD); Drug: carboplatin + paclitaxel (CP)
Sponsors: Konkuk University Medical Center; Seoul National University Hospital; National Cancer Center, Korea; Asan Medical Center; The Catholic University of Korea; Samsung Medical Center; Chung-Ang University Hosptial, Chung-Ang University College of Medicine; Ajou University; Severance Hospital
Recruiting - Condition: Exercise-induced Bronchospasm
Interventions: Dietary Supplement: Vitamin C; Other: Placebo
Sponsor: University of Kansas Medical Center
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Lindioil ointment; Drug: Protopic ointment 0.1%
Sponsors: Chang Gung Memorial Hospital; Ministry of Science and Technology, Taiwan
Not yet recruiting - Condition: Severe Asthma
Intervention:
Sponsors: Interregional Public Organization, Russian Respiratory Society; AstraZeneca Pharmaceuticals" LLC; Limited Liability Company Regional United System of Medical Informatization
Recruiting - Condition: Asthma
Interventions: Drug: Prednisolone; Drug: Placebo oral capsule
Sponsors: NHS Greater Glasgow and Clyde; Queen's University, Belfast
Not yet recruiting - Condition: Fibromyalgia
Intervention: Diagnostic Test: Functional Magnetic Resonance Imaging
Sponsor: Children's Hospital Medical Center, Cincinnati
Recruiting - Conditions: Allergic Diseases; Asthma
Interventions: Biological: C-section -Vaginal seeding; Drug: C-section - Placebo Seeding; Other: standard care
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network (ITN)
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Other: Adding menthoxypropanediol to the biopsy; Other: No adding menthoxypropanediol to the biopsy
Sponsors: University Hospital, Brest; Beiersdorf
Not yet recruiting - Conditions: Atopic Dermatitis; Skin Inflammation
Intervention: Device: Nevisense
Sponsors: Swiss Institute of Allergy and Asthma Research; CK-CARE (Christine Kühne – Center for Allergy Research and Education); SciBase AB
Recruiting - Conditions: Chlamydia Trachomatis Infection; Neisseria Gonorrheae Infection; Mycoplasma Genitalium Infection; Sensitivity; Polymerase Chain Reaction
Intervention: Diagnostic Test: Two samples on each of the three sites (pharynx, rectum, urine)
Sponsor: Centre Hospitalier Régional d'Orléans
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Upadacitinib; Drug: Placebo for Upadacitinib
Sponsor: AbbVie
Recruiting - Conditions: Not-celiac Wheat Sensitivity (NCWS); Familial Mediterranean Fever (FMF)
Interventions: Other: Wheat flour; Other: Placebo Comparator
Sponsor: University of Palermo
Not yet recruiting - Condition: Obesity
Interventions: Behavioral: sleep; Behavioral: exercise
Sponsor: University of Missouri-Columbia
Not yet recruiting - Condition: Tuberculosis
Interventions: Drug: GSK3036656; Drug: RIFAFOUR e-275
Sponsor: GlaxoSmithKline
Not yet recruiting - Condition: Allergy and Asthma
Intervention: Other: There is no intervention
Sponsor: Stanford University
Recruiting - Conditions: Hand Wound; Wrist Wound; Forearm Wound; Hand Fracture; Wrist Fracture; Forearm Fracture
Interventions: Drug: Dexamethasone; Drug: Normal saline
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - Condition: Atrial Fibrillation New Onset
Intervention: Diagnostic Test: Continuous Electrocardiogram
Sponsors: Population Health Research Institute; Hamilton Health Sciences Corporation
Not yet recruiting - Condition: Allergic Rhinitis
Interventions: Drug: Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT; Drug: Azelastine Hydrochloride 0.137 MG/ACTUAT; Drug: Fluticasone Propionate 0.05 MG/ACTUAT
Sponsor: MEDA Pharma GmbH & Co. KG
Recruiting - Conditions: Asthma in Children; Vaccine Adverse Reaction; Vaccine Reaction; Asthma; Wheezing; Influenza
Interventions: Biological: Live Attenuated Influenza Vaccine (LAIV); Biological: Inactivated Influenza Vaccine (IIV)
Sponsors: Vanderbilt University Medical Center; Centers for Disease Control and Prevention; Duke University; Children's Hospital Medical Center, Cincinnati
Not yet recruiting - Condition: Asthma
Intervention: Drug: Arnuity
Sponsor: GlaxoSmithKline
Not yet recruiting - Condition: Asthma
Intervention: Drug: Salbutamol
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting - Condition: Metastatic Hormone-Sensitive Prostate Cancer
Interventions: Biological: PROSTVAC-V; Biological: PROSTVAC-F; Drug: Nivolumab; Drug: Ipilimumab; Biological: Neoantigen DNA vaccine; Device: TriGrid Delivery System; Procedure: Tumor biopsy; Procedure: Peripheral blood; Procedure: Fecal samples
Sponsors: Washington University School of Medicine; Bristol-Myers Squibb
Recruiting - Conditions: Dermatitis, Atopic; Dermatitis; Eczema; Skin Diseases; Skin Diseases, Genetic; Genetic Diseases, Inborn; Skin Diseases, Eczematous; Hypersensitivity; Hypersensitivity, Immediate; Immune System Diseases
Interventions: Drug: Benralizumab; Drug: Placebo Control
Sponsors: McMaster University; AstraZeneca
Not yet recruiting - Condition: Chronic Spontaneous Urticaria
Interventions: Biological: Ligelizumab; Biological: Omalizumab; Other: Placebo
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - Condition: Chronic Spontaneous Urticaria
Interventions: Biological: Ligelizumab; Biological: Omalizumab; Other: Placebo
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - Conditions: Peanut Allergy; Tree Nut Allergy
Intervention: Other: Oral immunotherapy
Sponsor: McGill University Health Center
Recruiting - Conditions: Exercise Induced Bronchospasm; Athletes; Adolescent
Intervention: Diagnostic Test: EVH test
Sponsor: Universitaire Ziekenhuizen Leuven
Recruiting - Condition: Organoid
Intervention: Drug: Paclitaxel
Sponsor: Peking Union Medical College
Recruiting - Condition: Atopic Dermatitis
Intervention: Drug: Tralokinumab
Sponsor: LEO Pharma
Not yet recruiting - Conditions: Asthma in Children; Obesity, Childhood; Exercise Induced Bronchospasm
Interventions: Behavioral: Interval Warm-up exercise; Drug: Albuterol; Other: Control
Sponsor: University of Nevada, Las Vegas
Recruiting - Conditions: Relapsed Ovarian Cancer; Following Complete or Partial Response to Platinum Based Chemotherapy; Platinum Sensitive
Intervention: Drug: Olaparib 300mg tablets
Sponsor: AstraZeneca
Recruiting - Condition: Allergic Reaction
Intervention:
Sponsor: Centre Hospitalier Régional Metz-Thionville
Not yet recruiting - Conditions: Stevens-Johnson Syndrome; Toxic Epidermal Necrolysis; Drug Reaction
Intervention: Drug: Site specific standard of care comparison
Sponsor: Massachusetts General Hospital
Not yet recruiting - Condition: Atopic Dermatitis
Intervention: Drug: ATI-502
Sponsor: Aclaris Therapeutics, Inc.
Recruiting - Condition: Asthma in Children
Interventions: Behavioral: CASE Program; Behavioral: HARP Program
Sponsors: Rhode Island Hospital; State of Rhode Island Department of Health; Providence Public School District; Pawtucket School Department; Central Falls School District
Not yet recruiting - Condition: Henoch-Schönlein Purpura Nephritis
Interventions: Drug: Glycosides Of Tripterygium Wilfordii Hook(GTW); Drug: Sulfotanshinone Sodium Injection; Drug: Chinese herbs based on syndrome differentiation; Drug: Prednisone Acetate Tablets; Drug: Benazepril Hydrochloride Tablets; Drug: Low Molecular Weight Heparin Calcium Injection; Drug: Dipyridamole Tab 25 MG; Drug: Chinese medicine placebo
Sponsors: Henan University of Traditional Chinese Medicine; Peking University First Hospital; Children's Hospital of Fudan University; Shanghai Children's Hospital; Chengdu University of Traditional Chinese Medicine; Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
Recruiting - Condition: Child Behavior Problem
Interventions: Other: Circle of Security-Parenting; Other: Treatment as Usual
Sponsor: Region Syddanmark
Recruiting - Condition: Eosinophilic Esophagitis (EoE)
Intervention: Behavioral: Observed eating session
Sponsor: Mayo Clinic
Recruiting - Condition: Syncope
Intervention: Other: Measurement of hypersensitive troponin
Sponsor: University Hospital, Toulouse
Recruiting - Conditions: Obesity; Obesity; Endocrine; Insulin Sensitivity; Exercise
Intervention: Behavioral: Sprint Interval Training
Sponsor: University of New Brunswick
Not yet recruiting - Condition: Asthma
Interventions: Drug: PRS-060; Drug: Placebo
Sponsor: Pieris Australia Pty Ltd
Not yet recruiting - Condition: Neck Pain
Interventions: Other: Stretching and Spinal manipulative therapy; Other: Stretching
Sponsors: Karolinska Institutet; University of Southern Denmark
Not yet recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: PF-04965842 100 mg; Drug: PF-04965842 200 mg; Drug: Placebo
Sponsor: Pfizer
Recruiting - Condition: Allergy Pollen
Intervention: Diagnostic Test: Spiriplex Allergenex Microassay
Sponsor: United Allergy Services
Recruiting - Condition: Cough Variant Asthma
Interventions: Diagnostic Test: fractional exhaled nitric oxide(FeNO); Diagnostic Test: impulse oscillometry(IOS)
Sponsor: Zhujiang Hospital
Recruiting - Conditions: Dentine Hypersensitivity; Tooth Erosion
Interventions: Device: mouthguard; Device: mouthguard with desensitizing toothpaste
Sponsor: Khon Kaen University
Recruiting - Conditions: Prostate Cancer; Hormone-Dependent Prostate Cancer
Interventions: Drug: SHR3680; Drug: Bicalutamide
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Recruiting - Conditions: End-Stage Renal Disease; Diabetes Mellitus
Intervention: Drug: IV Novolin R human insulin
Sponsor: State University of New York - Downstate Medical Center
Recruiting - Condition: Atrial Fibrillation
Intervention:
Sponsors: Royal Devon and Exeter NHS Foundation Trust; University of Exeter
Not yet recruiting - Condition: Medicaments Substances in Therapeutic Use
Interventions: Other: Placebo gel + Normal Toothpaste; Other: Placebo Gel + Potassium Nitrate Toothpaste; Other: Potassium Nitrate Gel + Normal Toothpaste
Sponsors: Universidade Federal de Sergipe; Johnny Alexandre Oliveira Tavares
Not yet recruiting - Condition: Postoperative Sensitivity of Existing Dental Filling Materials
Intervention: Device: Fill-Up composite resin
Sponsor: University of Leeds
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Q301 Cream; Drug: Vehicle
Sponsor: Qurient Co., Ltd.
Not yet recruiting - Condition: Occupational Asthma
Intervention:
Sponsor: University Hospital, Strasbourg, France
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Upadacitinib; Drug: Placebo for Upadacitinib
Sponsor: AbbVie
Recruiting - Condition: Pre-Diabetes
Interventions: Dietary Supplement: Full-fat yogurt; Dietary Supplement: Non-fat yogurt
Sponsors: University of Vermont Medical Center; National Dairy Council
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Tradipitant; Drug: Placebo
Sponsor: Vanda Pharmaceuticals
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Upadacitinib; Drug: Placebo for Upadacitinib; Drug: Topical corticosteroids (TCS)
Sponsor: AbbVie
Recruiting - Condition: Moderate to Severe Atopic Dermatitis
Interventions: Drug: GBR 830 - Group 1; Drug: GBR 830 - Group 2; Drug: GBR 830 - Group 3:; Drug: Placebo - Group 4
Sponsor: Glenmark Pharmaceuticals S.A.
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: MOR 106; Drug: Placebo
Sponsor: Galapagos NV
Recruiting - Conditions: Dermatitis, Atopic; Eczema, Atopic; Neurodermatitis, Atopic
Interventions: Drug: Secukinumab 300 mg; Drug: Placebo
Sponsors: GWT-TUD GmbH; Novartis Pharmaceuticals
Not yet recruiting - Condition: Prostate Cancer
Intervention: Drug: Rucaparib
Sponsors: University of Utah; Clovis Oncology, Inc.
Recruiting - Conditions: Cardiovascular Risk Factor; Type2 Diabetes Mellitus; Insulin Sensitivity; Metabolic Syndrome
Interventions: Other: Naturally-sweetened orange juice; Other: Sugar-sweetened beverage
Sponsors: University of California, Davis; Touro University, California
Recruiting - Condition: Gall Stones, Common Bile Duct
Interventions: Diagnostic Test: Presence of bile duct stones; Diagnostic Test: Non-presence of bile duct stones
Sponsor: Hvidovre University Hospital
Not yet recruiting - Conditions: Pulmonary Disease, Chronic Obstructive; Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome; Small Airway Disease; Quality of Life
Intervention: Drug: Budesonide(160ug) and Formoterol(4.5ug) bid
Sponsor: Zhujiang Hospital
Recruiting - Condition: Asthma
Interventions: Drug: Test Product; Drug: Reference Product; Drug: Placebo
Sponsor: Amneal Ireland Limited
Not yet recruiting - Condition: Asthma
Interventions: Drug: Test Product; Drug: Reference Product; Drug: Placebo
Sponsor: Amneal Ireland Limited
Not yet recruiting - Conditions: Asthma Persistent; Asthma, Allergic; Eosinophilic Asthma; Chronic Rhinosinusitis (Diagnosis)
Intervention:
Sponsor: TC Erciyes University
Recruiting - Condition: Ovarian Cancer
Interventions: Drug: BGB-290 capsule; Drug: Placebo capsule
Sponsor: BeiGene
Recruiting - Condition: Asthma
Interventions: Drug: Mepolizumab 100 milligrams; Drug: Placebo; Drug: Salbutamol
Sponsor: GlaxoSmithKline
Not yet recruiting - Conditions: Vascular Stiffness; Insulin Sensitivity
Interventions: Drug: Octreotide; Drug: Insulin; Drug: Dextrose 20% solution
Sponsors: University of Virginia; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: Asthma
Interventions: Drug: Dupilumab (SAR231893/REGN668); Drug: Asthma controller therapies (incl. prednisone/prednisolone); Drug: Asthma reliever therapies
Sponsors: Sanofi; Regeneron Pharmaceuticals
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Tralokinumab; Drug: Placebo; Biological: Tdap vaccine; Biological: Meningococcal vaccine
Sponsor: LEO Pharma
Recruiting - Condition: Breast Cancer
Interventions: Drug: ZN-c5; Drug: Palbociclib
Sponsor: Zeno Alpha Inc.
Not yet recruiting - Conditions: Nonalcoholic Fatty Liver Disease (NAFLD); Nonalcoholic Steatohepatitis (NASH)
Intervention: Device: Acoustic radiation force impulse, magnetic resonance elastography
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); McGill University Health Center; Canadian Institutes of Health Research (CIHR); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Not yet recruiting - Condition: Penicillin Allergy
Intervention: Drug: Amoxicillin
Sponsor: Clalit Health Services
Not yet recruiting - Conditions: Prostate Cancer; Stage IV Prostate Cancer; Advanced Prostate Cancer; Adenocarcinoma of the Prostate
Interventions: Drug: Adaptive Androgen Deprivation Therapy (ADT); Drug: Abiraterone; Drug: Prednisone
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Recruiting - Condition: Iron-deficiency
Intervention: Behavioral: hypersensitivity reaction
Sponsor: University Hospital, Basel, Switzerland
Recruiting - Condition: Food Allergy
Interventions: Biological: Cashew Oral Immunotherapy; Biological: Shrimp Oral Immunotherapy; Biological: Milk Oral Immunotherapy
Sponsor: Kari Christine Nadeau, MD PhD
Not yet recruiting - Condition: Asthma
Intervention: Biological: Benralizumab
Sponsor: AstraZeneca
Recruiting - Condition: Allergic Rhinitis
Interventions: Drug: Dupilumab; Drug: Timothy Grass SCIT; Drug: Placebo matching dupilumab; Drug: Placebo matching SCIT
Sponsors: Regeneron Pharmaceuticals; Sanofi
Recruiting - Condition: Atopic Dermatitis
Intervention:
Sponsor: Wake Forest University Health Sciences
Not yet recruiting - Condition: Repetitive Abdominal Pain Attacks of Undetermined Etiology
Intervention:
Sponsor: Centogene AG Rostock
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Tralokinumab; Drug: Caffeine; Drug: Warfarin; Drug: Omeprazole; Drug: Metoprolol; Drug: Midazolam Hydrochloride
Sponsor: LEO Pharma
Not yet recruiting - Conditions: Vernal Keratoconjunctivitis; Atopic Keratoconjunctivitis; Tacrolimus
Intervention:
Sponsor: National Taiwan University Hospital
Recruiting - Condition: Atopic Dermatitis
Intervention: Drug: Ivermectin Pill
Sponsor: Stanford University
Not yet recruiting - Conditions: Ultrasonography; Peroneal Neuropathies
Intervention: Diagnostic Test: Ultrasound protocol
Sponsors: Sándor Beniczky; Aarhus University Hospital
Recruiting - Condition: Asthma
Interventions: Drug: Placebo; Drug: 90 mcg Reference Product; Drug: 180 mcg Reference Product; Drug: 90 mcg Test Product
Sponsor: Amneal Ireland Limited
Recruiting - Conditions: Exercise Induced Asthma; Exercise Induced Pharyngeal Collapse
Interventions: Other: ECC; Other: ECC with CLE; Other: Speech therapy
Sponsor: Johann Wolfgang Goethe University Hospital
Not yet recruiting - Condition: Gene Mutation in Infantile Onset Diabetes Mellitus
Intervention:
Sponsor: Shimaa Kamal
Not yet recruiting - Condition: Atopic Dermatitis
Intervention:
Sponsors: UMC Utrecht; Academisch Ziekenhuis Groningen; Radboud University
Recruiting - Conditions: Insulin Sensitivity; Sleep; Dietary Habits
Intervention: Behavioral: Sleep Extension
Sponsor: University of Colorado, Denver
Recruiting - Conditions: Differentiated Thyroid Gland Carcinoma; Thyroid Gland Follicular Carcinoma; Thyroid Gland Papillary Carcinoma
Intervention: Drug: Lenvatinib
Sponsors: Emory University; Eisai Inc.
Not yet recruiting - Condition: GERD
Interventions: Drug: Citalopram 20mg; Drug: Placebo Oral Tablet
Sponsor: Universitaire Ziekenhuizen Leuven
Not yet recruiting - Condition: Asthma in Children
Interventions: Other: TEAM-UP Intervention Group; Other: Enhanced Care Comparison
Sponsors: University of Rochester; University of Arkansas; University at Buffalo
Not yet recruiting - Conditions: Urticaria; Angiœdema
Interventions: Drug: Placebo Oral Tablet; Drug: Cortancyl Oral Tablet; Drug: Levocetirizine Oral Tablet
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting - Conditions: Psoriasis; Atopic Dermatitis
Interventions: Other: EDP1066; Drug: Placebo oral capsule
Sponsor: Evelo Biosciences, Inc.
Recruiting - Condition: Atopic Dermatitis Eczema
Interventions: Drug: Administration of Placebo; Drug: Administration of PUR0110 (Thykamine) 0.05%; Drug: Administration of PUR0110 (Thykamine) 0.1%; Drug: Administration of PUR0110 (Thykamine) 0.25%
Sponsor: PurGenesis Technologies Inc.
Recruiting - Conditions: Pruritus; Prurigo Nodularis; Atopic Dermatitis; Psoriasis
Intervention: Drug: 5 mg Serlopitant Tablets
Sponsor: Menlo Therapeutics Inc.
Recruiting - Condition: Allergic Reaction
Intervention: Procedure: Skin test endpoint titration
Sponsor: University of Saskatchewan
Recruiting - Conditions: Malaria Diagnosis; Malaria,Falciparum
Intervention: Diagnostic Test: hsRDT
Sponsors: University Research Co, LLC; Duke University; United States Agency for International Development (USAID); Department of Medical Research, Lower Myanmar; Centers for Disease Control and Prevention
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Crisaborole ointment, 2%; Drug: Hydrocortisone butyrate cream, 0.1%; Drug: Pimecrolimus cream, 1%; Drug: Crisaborole Vehicle
Sponsor: Pfizer
Recruiting - Condition: Asthma
Intervention: Behavioral: My Asthma in School
Sponsor: Queen Mary University of London
Recruiting - Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)Condition: Asthma
Interventions: Drug: Fluticasone propionate/salmeterol; Drug: Advair Diskus, 100 Mcg-50 Mcg Inhalation Powder; Drug: Placebo
Sponsor: West-Ward Pharmaceutical
Recruiting - Conditions: Primary Invasive Breast Cancer; Estrogen Receptor Positive Tumor; Human Epidermal Growth Factor Receptor 2 Negative Tumor
Intervention: Other: Observation
Sponsors: North Eastern Germany Society of Gynaecologic Oncology; Center for Clinical Trials Philipps University Marburg
Recruiting - Conditions: Hallux Valgus and Bunion (Disorder); Morton Neuroma; Metatarsal Fracture; Ingrown Nail; Foot Wound; Foot Infection
Intervention: Procedure: Specific block of medial and lateral plantar nerves
Sponsor: CMC Ambroise Paré
Recruiting - Conditions: Asthma; Obesity
Interventions: Drug: Roflumilast 500 Mcg Oral Tablet; Drug: Placebo oral capsule
Sponsors: Johns Hopkins University; American Lung Association; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Conditions: Severe Asthma; Obesity
Intervention: Procedure: Bariatric
Sponsors: University of Sao Paulo General Hospital; AstraZeneca
Not yet recruiting - Conditions: Muscle Atrophy; Insulin Sensitivity
Interventions: Other: Bed Rest; Other: Reconditioning
Sponsor: University of Nottingham
Recruiting - Condition: Mild -Moderate Anaphylaxis - Symptoms That Affect the Skin With Cardiovascular, Respiratory or Gastrointestinal Involvement, But no Signs of Hypotension ,Laryng
Intervention: Drug: Dexamethasone Oral
Sponsor: Hamad Medical Corporation
Recruiting - Condition: Atopic Dermatitis
Interventions: Biological: ANB020; Drug: Placebo
Sponsor: AnaptysBio, Inc.
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: ASN002; Drug: Placebo Oral Tablet
Sponsor: Asana BioSciences
Recruiting - Conditions: Tumor Disease Including Colorectal Cancer; Head & Neck Squamous Cell Carcinoma
Intervention:
Sponsor: Yonsei University
Recruiting - Condition: Coronary Artery Disease
Interventions: Drug: Vericiguat (BAY1021189); Drug: Moxifloxacin; Drug: Placebo
Sponsors: Bayer; Merck Sharp & Dohme Corp.
Recruiting - Condition: Asthma
Interventions: Drug: Zero-dose; Drug: 90 mcg of PROAIR® HFA; Drug: 180 mcg of 90 mcg of PROAIR® HFA; Drug: 90 mcg of albuterol sulfate inhalation aerosol
Sponsor: Sun Pharmaceutical Industries Limited
Not yet recruiting - Condition: Prostate Cancer
Interventions: Drug: SUBA-itraconazole; Drug: Hydroxychloroquine
Sponsor: St Vincent's Hospital, Sydney
Recruiting - Conditions: NASH - Nonalcoholic Steatohepatitis; Insulin Sensitivity
Intervention: Device: Electro-muscular stimulation using NeuroTrac MyoPlus 2/4
Sponsor: NHS Tayside
Recruiting - Conditions: Overactive Bladder Syndrome; Bladder Outlet Obstruction; Benign Prostate Enlargement; Stress Incontinence (Female) (Male); Bladder Disease
Intervention: Other: IPSS questionnaire
Sponsor: Assaf-Harofeh Medical Center
Recruiting - Condition: Exercise Induced Asthma
Interventions: Other: Exercise induced bronchoconstriction; Other: Inhibited EIB
Sponsors: Brunel University; Karolinska Institutet
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Tralokinumab; Drug: Placebos
Sponsor: LEO Pharma
Recruiting - Condition: Chronic Low Back Pain
Interventions: Behavioral: Culturally sensitive pain education; Behavioral: Standard pain education program
Sponsor: Hacettepe University
Not yet recruiting - Conditions: Muscle Hypersensitivity; Pain Response; Healthy Subjects
Intervention: Drug: NGF/Isotonic saline
Sponsor: Aalborg University
Recruiting - Condition: Prostate Adenocarcinoma
Intervention: Diagnostic Test: F-18 fluciclovine-PET/CT scan
Sponsors: University of Arizona; Blue Earth Diagnostics; Banner University Medical Center
Recruiting - Condition: Asthma
Intervention: Other: Pediatric ASTHMA-Educator mobile application
Sponsor: Montefiore Medical Center
Recruiting - Condition: Atopic Diseases
Interventions: Other: Hydrolyzed Formula; Other: Control formula
Sponsor: HiPP GmbH & Co. Vertrieb KG
Not yet recruiting - Condition: Training Group, Sensitivity
Intervention: Device: Microcurrent
Sponsors: University of Greenwich; Arc Family
Recruiting - Condition: IgE-mediated Milk Allergy
Intervention: Other: Milk
Sponsor: Hospital San Carlos, Madrid
Not yet recruiting - Condition: Food Allergy
Interventions: Drug: Glucopyranosyl Lipid A (GLA); Drug: Sublingual Immuno Therapy (SLIT) Peanut Extract (PE); Drug: Placebo for GLA; Drug: Placebo for SLIT PE
Sponsor: Sanofi
Recruiting - Condition: NSTEMI - Non-ST Segment Elevation MI
Intervention:
Sponsors: Marco Marchetti; Azienda Ospedaliero Universitaria Maggiore della Carita; Azienda Sanitaria Locale ASL 6, Livorno; Azienda Ospedaliera Spedali Civili di Brescia; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Ospedale Civile - Padova; S. Andrea Hospital; Azienda Policlinico Umberto I; San Carlo Public Hospital, Potenza, Italy; Azienda Ospedaliero-Universitaria Consorziale; Policlinico Universitario, Catania; Azienda Ospedaliera Sant'Anna; Ospedale di Cattinara - Azienda Universitaria Integrata -Trieste; Abbott s.r.l.; Informapro Srl
Recruiting - Conditions: Visceral Hypersensitivity; Irritable Bowel Syndrome
Intervention: Drug: Rifaximin
Sponsors: Cedars-Sinai Medical Center; Valeant Pharmaceuticals International, Inc.
Not yet recruiting - Condition: Cow Milk Allergy
Intervention: Diagnostic Test: skin prick test - specific serum IgE
Sponsor: Assiut University
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Placebo; Drug: ZPL389
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - Condition: Tuberculosis, Pulmonary
Interventions: Drug: Rifampicin; Drug: Isoniazid; Drug: Pyrazinamide; Drug: Ethambutol; Drug: Linezolid; Drug: Clofazimine; Drug: Rifapentine; Drug: Levofloxacin; Drug: Bedaquiline
Sponsors: University College, London; National University Hospital, Singapore; Singapore Clinical Research Institute (SCRI)
Recruiting - Conditions: Diabetes Mellitus; Endocrine System Diseases; Glucose Metabolism Disorders; PreDiabetes; Obesity
Interventions: Drug: GSK2256294; Drug: Placebo oral capsule
Sponsor: Vanderbilt University Medical Center
Recruiting - Conditions: Asthma; Asthma in Children
Interventions: Behavioral: Incentives; Behavioral: Medication device monitoring and reminders
Sponsor: University of Colorado, Denver
Recruiting - Conditions: Childhood Asthma; Community Health Workers
Interventions: Behavioral: Yes We Can Children's Asthma Program; Behavioral: School-Based Asthma Therapy; Behavioral: Open Airways for School Plus
Sponsors: Children's Hospital of Philadelphia; University of Pennsylvania; Education Plus Health; School District of Philadelphia; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Papillary Thyroid Cancer
Intervention: Drug: Imatinib Oral Tablet
Sponsors: AHS Cancer Control Alberta; Alberta Cancer Foundation
Not yet recruiting - Condition: EGFR-sensitive Mutation-positive Advanced Non-squamous Non-small Cell Lung Cancer Treated With S-1plus Gefitinib Versus Gefitinib Monotherapy
Interventions: Drug: S-1 plus Gefitinib; Drug: Gefitinib
Sponsor: Henan Cancer Hospital
Not yet recruiting - Conditions: Diabetes Mellitus, Type 2; Insulin Resistance; Insulin Sensitivity
Intervention: Drug: Intralipid, 20% Intravenous Emulsion
Sponsor: University of Pennsylvania
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: LEO 138559; Drug: LEO 138559 placebo
Sponsor: LEO Pharma
Recruiting - Condition: Allergy Milk
Interventions: Dietary Supplement: extensively hydrolyzed casein formula + LGG; Dietary Supplement: Hypoallergenic formula based on amino-acid based formula
Sponsor: Federico II University
Not yet recruiting - Condition: Asthma
Interventions: Device: myAsthma Application; Device: Lloyds Pharmacy Online Doctor
Sponsors: my mhealth Ltd; Expert Health Ltd; CLAHRC Wessex
Not yet recruiting - Condition: Epilepsy
Intervention: Other: Measure of emotional stressors
Sponsor: University Hospital, Toulouse
Recruiting - Conditions: Asthma; Physical Activity
Intervention:
Sponsor: Gazi University
Recruiting - Condition: Asthma
Intervention:
Sponsors: Seoul National University Hospital; SMG-SNU Boramae Medical Center
Not yet recruiting - Condition: NSCLC
Intervention:
Sponsor: K2 Oncology, Inc.
Recruiting - Conditions: Asthma; Wheezing; Cough; Exercise Induced Bronchospasm; Vocal Cord Dysfunction
Intervention:
Sponsors: University of Bern; University Children's Hospital, Zurich; Cantonal Hospital, Lucerne; University Children's Hospital Basel, UKBB; University Hospital Inselspital, Bern; Children's Hospital of St. Gallen
Recruiting - Condition: Allergy
Interventions: Combination Product: Streptococcus salivarius 24SMBc + Strept. oralis 89a; Combination Product: fluticasone + mometasone; Other: placebo
Sponsor: Federico II University
Not yet recruiting - Condition: Asthma-COPD Overlap
Interventions: Drug: triple combinations; Drug: double combinations
Sponsor: Huashan Hospital
Not yet recruiting - Conditions: Asthma in Children; Atrial Fibrillation
Interventions: Behavioral: Intervention (1) for outdoor exposure reduction - Asthma in Children; Behavioral: Intervention (2) for outdoor and indoor exposure reduction - Asthma in Children; Behavioral: Intervention (1) for outdoor exposure reduction - Atrial Fibrillation; Behavioral: Intervention (2) for outdoor and indoor exposure reduction - Atrial Fibrillation
Sponsors: University of Cyprus; University of Crete; Soroka University Medical Center; Cyprus University of Technology; Cyprus Department of Labor Inspection; Cyprus Department of Meteorology; Cyprus Broadcasting Corporation; E.n.A Consulting LP
Not yet recruiting - Condition: Allergic Conjunctivitis
Interventions: Drug: Reproxalap Ophthalmic Solution (0.25%); Drug: Reproxalap Ophthalmic Solution (0.5%); Drug: Vehicle Ophthalmic Solution
Sponsor: Aldeyra Therapeutics, Inc.
Recruiting - Condition: Chronic Spontaneous Urticaria
Intervention: Drug: Nucala
Sponsors: Mayo Clinic; GlaxoSmithKline
Not yet recruiting - Conditions: Aspirin-Sensitive Asthma With Nasal Polyps; Samter's Syndrome
Interventions: Dietary Supplement: Water; Dietary Supplement: Red wine; Dietary Supplement: Polyphenolic Compounds
Sponsor: University of Virginia
Recruiting - Condition: Insulin Sensitivity
Interventions: Drug: Metformin; Drug: Pioglitazone; Drug: Placebo
Sponsor: Wayne State University
Not yet recruiting - Conditions: Plasmodium Falciparum Malaria; Pregnancy Malaria; Diagnoses Disease
Intervention: Diagnostic Test: HS-RDT
Sponsors: Foundation for Innovative New Diagnostics, Switzerland; Burnet Institute; Papua New Guinea Institute of Medical Research
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Bermekimab Monoclonal Antibody 200 mg; Drug: Bermekimab Monoclonal Antibody 400 mg
Sponsor: XBiotech, Inc.
Recruiting - Condition: Childhood Asthma With Status Asthmaticus
Interventions: Drug: Salbutamol; Drug: Sodium Chloride 0.9%
Sponsor: Erasmus Medical Center
Recruiting - Condition: Eosinophilic Gastritis
Interventions: Drug: AK002; Other: Placebo
Sponsor: Allakos, Inc.
Recruiting - Conditions: Healthy Volunteers; Anti-Bacterial Agents; Methicillin-Resistant Staphylococcus Aureus; Methicillin-Sensitive Staphylococcus Aureus Infection
Interventions: Biological: N-Rephasin® SAL200; Other: INT200-Placebo
Sponsor: Intron Biotechnology, Inc.
Recruiting - Condition: Ovarian Cancer
Intervention: Drug: Trabectedin + PLD
Sponsors: Suriya Yessentayeva; Johnson & Johnson
Recruiting - Condition: Keratopathy
Intervention: Procedure: keratoplasty
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University
Recruiting - Condition: Hypertension
Intervention: Diagnostic Test: WatchBP Office (BP measurement machine)
Sponsor: Chinese University of Hong Kong
Not yet recruiting - Conditions: Atopic Dermatitis; Pruritus; Sleep Disturbance
Intervention:
Sponsors: University of Rochester; Pfizer
Recruiting - Condition: Allergic Conjunctivitis
Interventions: Drug: Bilastine Ophthalmic Solution 0.6%; Drug: Ketotifen Ophthalmic Solution 0.025% (Zaditen); Drug: Vehicle of Bilastine Ophthalmic Solution
Sponsors: Faes Farma, S.A.; ORA, Inc.
Recruiting - Condition: Asthma
Intervention: Behavioral: Internet-CBT for anxiety-related asthma
Sponsor: Karolinska Institutet
Recruiting - Conditions: Hereditary Angioedema; HAE
Interventions: Drug: BCX7353 capsules; Drug: Placebo oral capsule
Sponsor: BioCryst Pharmaceuticals
Recruiting - Conditions: Chronic Eczema; Psoriasis; Atopic Dermatitis
Intervention: Combination Product: ACE CSD
Sponsor: Ace Cells Lab Limited
Not yet recruiting - Condition: Social Cognition
Intervention:
Sponsor: University Hospital, Basel, Switzerland
Recruiting - Condition: Pleural Effusion
Interventions: Device: Mini-thoracoscopy; Device: Conventional rigid thoraoscopy
Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting - Conditions: Breast Adenocarcinoma; Recurrent Breast Carcinoma; Recurrent Hodgkin Lymphoma; Recurrent Mycosis Fungoides; Recurrent Non-Hodgkin Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Nodal Marginal Zone Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage IV Breast Cancer AJCC v6 and v7
Interventions: Drug: Belinostat; Drug: Carfilzomib; Biological: Daratumumab; Drug: Fludeoxyglucose F-18; Drug: Gemcitabine Hydrochloride; Other: Laboratory Biomarker Analysis; Biological: Nivolumab; Biological: Obinutuzumab; Biological: Pembrolizumab; Procedure: Positron Emission Tomography; Biological: Rituximab; Drug: Romidepsin; Other: Saline; Biological: Trastuzumab
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting - Conditions: Hematologic Diseases; Treatment
Intervention: Diagnostic Test: ex-vivo drug response assay
Sponsors: German Cancer Research Center; University Hospital Heidelberg
Recruiting - Condition: Asthma
Interventions: Drug: Placebo DPI; Device: ELLIPTA DPI; Other: Ease of use questionnaires
Sponsor: GlaxoSmithKline
Recruiting - Condition: Neutrophilic Asthma
Intervention: Diagnostic Test: Induced sputum
Sponsors: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Spanish Clinical Research Network - CAIBER
Recruiting - Conditions: Celiac Disease; Gluten Sensitivity; Gluten Enteropathy; Gastrointestinal Disease; Digestive System Disease; Diet Modification; Intestinal Disease; Malabsorption Syndromes; Patient Compliance; Diagnostic Self Evaluation; Quality of Life
Intervention: Device: Immunochromatographic lateral flow test
Sponsors: Boston Children’s Hospital; Glutenostics, LLC
Recruiting - Condition: GI Patients on Oxaliplatin Containing Regimen
Intervention: Drug: Oxaliplatin
Sponsor: Abramson Cancer Center of the University of Pennsylvania
Recruiting - Condition: Severe Asthma
Interventions: Drug: Randomisation to omalizumab; Drug: Randomisation to mepolizumab
Sponsors: Cliniques universitaires Saint-Luc- Université Catholique de Louvain; University Hospital, Ghent; University Hospital of Liege; CHU de Charleroi; Erasme University Hospital; Centre Hospitalier Universitaire Dinant Godinne - UCL Namur; Universitair Ziekenhuis Brussel; Brugmann University Hospital; Grand Hôpital de Charleroi; AZ Delta Roeselare; Centre Hospitalier Universitaire Saint Pierre; KU Leuven
Not yet recruiting - Conditions: Anhedonia; Depression; Anxiety
Interventions: Behavioral: Positive Affect Treatment; Behavioral: Negative Affect Treatment
Sponsors: University of California, Los Angeles; Southern Methodist University
Recruiting - Condition: Dermatologic Disease
Intervention: Diagnostic Test: Serum serotonin level
Sponsor: Assiut University
Not yet recruiting - Conditions: Non-Alcoholic Fatty Liver Disease; Insulin Resistance
Interventions: Dietary Supplement: L-Carnitine tartrate; Dietary Supplement: Meal Replacement Drink; Dietary Supplement: Maltodextrin
Sponsors: University of Nottingham; Nottingham University Hospitals NHS Trust; National Institute for Health Research, United Kingdom
Recruiting - Condition: Prostate Cancer Metastatic
Intervention: Drug: Rucaparib
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not yet recruiting - Conditions: MTA; Calcium Hydroxide; Dental Crown
Interventions: Procedure: Temporary cement based on Calcium Hydroxide; Procedure: MTA temporary cement
Sponsor: Federal University of Uberlandia
Recruiting - Conditions: MTA; Dental Restoration, Temporary
Interventions: Procedure: Carie removal; Procedure: Relative isolation; Procedure: Manipulation of the temporary material based on Zinc Oxide and Eugenol; Procedure: Manipulation of the temporary material based on Mineral trioxide aggregate; Procedure: Material insertion on the cavity; Procedure: Finishing the temporary direct restoration
Sponsor: Federal University of Uberlandia
Not yet recruiting - Condition: Eosinophilic Gastritis or Gastroenteritis
Interventions: Biological: Benralizumab; Biological: Placebo
Sponsors: Children's Hospital Medical Center, Cincinnati; AstraZeneca
Recruiting - Condition: Asthma, Allergic
Interventions: Drug: CMAB007; Drug: Symbicort; Drug: Seretide; Drug: Ventolin; Drug: placebo
Sponsor: Shanghai Biomabs Pharmaceutical Co., Ltd.
Recruiting - Condition: Eosinophilic Asthma
Interventions: Drug: ANB020; Drug: Placebo
Sponsor: AnaptysBio, Inc.
Recruiting - Conditions: Hereditary Angioedema; HAE; Prophylaxis
Intervention: Drug: BCX7353
Sponsor: BioCryst Pharmaceuticals
Recruiting - Condition: Microbiota
Interventions: Drug: Methimazole Pill; Drug: Propylthiouracil Pill
Sponsor: First Affiliated Hospital of Harbin Medical University
Recruiting - Condition: Primary Pterygium
Intervention: Procedure: Pterygium surgery
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University
Recruiting - Condition: Tooth Sensitivity
Interventions: Device: Experimental: • Group LA; Device: Placebo Comparator: • Group LA-P; Other: Experimental: • Group DE; Other: Placebo Comparator: • Group DE-P; Other: Experimental: • Group RGI; Other: Experimental: Group RX
Sponsor: University of Sao Paulo
Recruiting - Conditions: Atopic Dermatitis; Atopic Disorders; Eczema; Atopic Eczema
Intervention: Other: Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream
Sponsors: Oregon Health and Science University; University of Wisconsin, Madison; University of Colorado, Denver; Duke University
Not yet recruiting - Condition: Seasonal Allergic Rhinitis (SAR)
Interventions: Drug: GSP 301 NS; Drug: GSP 301 Placebo NS
Sponsor: Glenmark Specialty S.A.
Recruiting - Condition: Asthma
Interventions: Drug: Salmeterol Xinafoate and Fluticasone Propinate Powder; Drug: Seretide
Sponsor: Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Recruiting - Conditions: Suxamethonium Sensitivity; Aspiration of Gastric Contents Into Respiratory Tract, Part Unspecified
Intervention:
Sponsor: University Hospital, Caen
Recruiting - Condition: Insulin Sensitivity
Intervention: Other: Hi GI
Sponsors: Purdue University; Federico II University; University of Agriculture Science, Uppsala, Sweden
Recruiting - Condition: Bladder Cancer
Intervention: Device: BladderLight®
Sponsors: Cambridge University Hospitals NHS Foundation Trust; Cytosystems Ltd
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Topical coal tar; Drug: Topical corticosteroids
Sponsor: Radboud University
Recruiting - Condition: Asthma
Intervention:
Sponsor: Heart of England NHS Trust
Not yet recruiting - Condition: Obese, Pre-diabetics
Interventions: Behavioral: High-intenstiy interval training; Dietary Supplement: Insulinogenic, carbohydrate-rich drink
Sponsors: Maastricht University; Netherlands Organisation for Scientific Research
Recruiting - Condition: Asthma, Allergic
Interventions: Procedure: Bronchoscopy/BAL; Procedure: Airway Brushing; Procedure: Endobronchial Biopsy
Sponsors: Andrew D. Luster, M.D.,Ph.D.; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Conditions: Penicillin Allergy; Pediatric Emergency Medicine
Intervention: Drug: Amoxicillin
Sponsor: Medical College of Wisconsin
Recruiting - Conditions: Myopia, Progressive; Atropine Allergy
Intervention: Drug: eye drops
Sponsor: Chang Gung Memorial Hospital
Recruiting - Condition: Asthma
Interventions: Drug: Foster 100/6mg NEXThaler; Drug: Foster 100/6mg pMDI
Sponsor: Chiesi Farmaceutici S.p.A.
Recruiting - Conditions: Castration Levels of Testosterone; Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma in the Soft Tissue; Prostate Carcinoma Metastatic in the Bone; Stage IV Prostate Adenocarcinoma AJCC v7
Interventions: Drug: Abiraterone Acetate; Drug: Antiandrogen Therapy; Drug: Cabazitaxel; Other: Laboratory Biomarker Analysis; Procedure: Orchiectomy; Other: Pharmacological Study; Drug: Prednisone
Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI)
Recruiting - Condition: Obesity
Intervention: Behavioral: Health Smart for Weight Loss
Sponsors: University of Florida; Patient-Centered Outcomes Research Institute
Recruiting - Conditions: Coronary Artery Disease; Anesthesia
Interventions: Procedure: transcutaneous acupoint electrical stimulation; Procedure: sham transcutaneous acupoint electrical stimulation
Sponsor: Hebei Medical University Third Hospital
Recruiting - Condition: Chronic Urticaria
Interventions: Procedure: Punch Biopsy; Procedure: Blood sampling
Sponsor: Olivier Michel
Recruiting - Conditions: Asthma; Mastocytosis; Mast Cell Activation Syndrome; Food Allergy; Chronic Idiopathic Urticaria; Anaphylaxis; Eczema
Intervention:
Sponsors: Hong Kong Sanatorium & Hospital; Chinese University of Hong Kong; Stanford University
Recruiting - Condition: Non-Germline BRCA Mutated Ovarian Cancer
Intervention: Drug: Olaparib
Sponsors: AstraZeneca; Quintiles, Inc.; Myriad Genetics, Inc.; Covance; Theradex; Parexel
Recruiting - Condition: Cough
Intervention: Drug: Ambroxol Hydrochloride
Sponsors: Hull and East Yorkshire Hospitals NHS Trust; Sanofi
Not yet recruiting - Conditions: Asthma; COPD
Intervention: Behavioral: Inhaler technique education
Sponsor: Aveiro-Aradas Family Health Unit
Not yet recruiting - Condition: High Functioning Autism Spectrum Disorder
Intervention:
Sponsor: Rambam Health Care Campus
Not yet recruiting - Condition: Chronic Spontaneous Urticaria
Interventions: Drug: Ligelizumab; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - Condition: Asthma
Interventions: Behavioral: ASMAS; Behavioral: Asthma education plus child health
Sponsors: Rhode Island Hospital; University of Puerto Rico
Not yet recruiting - Conditions: Renal Insufficiency, Chronic; Chronic Kidney Diseases
Intervention: Other: salt restriction education
Sponsor: Peking University First Hospital
Not yet recruiting - Condition: Eosinophilic Esophagitis
Intervention: Device: MRI to detect inflammation and fibrosis in subjects with EoE
Sponsor: Mayo Clinic
Recruiting - Conditions: Advanced Malignancies; Urothelial Carcinoma; MSI-H or dMMR Solid Tumors; Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Interventions: Drug: Apatinib; Drug: Pembrolizumab
Sponsors: University of Utah; LSK BioPartners Inc.
Recruiting - Condition: Atopic Dermatitis
Interventions: Biological: Lebrikizumab; Drug: Placebos
Sponsor: Dermira, Inc.
Recruiting - Conditions: Cataracts; Visual Acuity Reduced Transiently; Loss of Visual Contrast Sensitivity; Functional Visual Loss
Interventions: Device: Alcon 1 piece SA60AT lens; Device: AMO 1-piece AABOO lens
Sponsors: University of Toronto; Kensington Eye Institute
Recruiting - Condition: Atopic Dermatitis
Intervention: Device: BAY987534
Sponsor: Bayer
Not yet recruiting - Condition: Asthma in Children
Interventions: Other: asthma action plan management group; Other: conventional management group
Sponsors: Beijing Children's Hospital; Tian Jing Children’s Hospital; Capital Institute of Pediatrics, China; Peking University Third Hospital; Beijing Tsinghua Chang Gung Hospital; Tianjin Medical University Second Hospital; Peking University Bin Hai Hospital; The First Hospital of Qinhuangdao; Tangshan Maternal and Child Health Hospital; Children's Hospital of Hebei Province
Not yet recruiting - Condition: Severe Asthma
Intervention:
Sponsors: Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - Conditions: Plasma Cell Leukemia; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Interventions: Procedure: Biospecimen Collection; Device: High Throughput Screening; Other: Laboratory Biomarker Analysis
Sponsors: University of Washington; National Cancer Institute (NCI)
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Baricitinib; Drug: Placebo
Sponsors: Eli Lilly and Company; Incyte Corporation
Recruiting - Condition: Cold Hypersensitivity
Interventions: Drug: Sipjeondaebo-tang Granule; Drug: Placebo
Sponsors: Gachon University Gil Oriental Medical Hospital; Kyunghee University Oriental Medical Center; Kyung Hee University Hospital at Gangdong; Semyung University second affiliated oriental medical hospital at Chungju; Sangji University Oriental Medical Hospital
Recruiting - Conditions: Anxiety Disorders; Anxiety; Tobacco Dependence; Smoking, Cigarette; Smoking, Tobacco
Interventions: Behavioral: Personalized Feedback Intervention; Behavioral: Smoking Information Control
Sponsors: University of Houston; National Institute on Drug Abuse (NIDA)
Recruiting - Conditions: EGFR Gene Mutation; Non Small Cell Lung Cancer Stage IIIA; Non Small Cell Lung Cancer Stage IIIB
Intervention: Drug: Icotinib
Sponsor: Betta Pharmaceuticals Co.,Ltd.
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Baricitinib; Drug: Placebo; Drug: Topical corticosteroid
Sponsors: Eli Lilly and Company; Incyte Corporation
Recruiting - Condition: Dermatitis, Atopic
Intervention: Drug: Dupilumab
Sponsors: Regeneron Pharmaceuticals; Sanofi
Recruiting - Conditions: Asthma; COPD; Asthma-COPD Overlap Syndrome
Intervention: Other: No any intervention
Sponsor: Mahidol University
Recruiting - Condition: Allergic Hypersensitivity Drug Reaction Versus Non-allergic Hypersensitivity Drug Reaction Cross Reaction
Intervention:
Sponsor: University Hospital, Grenoble
Recruiting - Conditions: Asthma; Child; Respiratory Disease; Hydrotherapy; Respiratory Tract Diseases; Respiratory Hypersensitivity; Respiration Disorders
Interventions: Other: Ai Chi; Other: Asthma education
Sponsor: Universidade Federal do Rio Grande do Norte
Recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: PF-04965842 100 mg; Drug: PF-04965842 200 mg; Drug: Placebo
Sponsor: Pfizer
Recruiting - Condition: Lung Cancer
Intervention: Drug: Gefitinib
Sponsors: Qilu Pharmaceutical Co., Ltd.; China-Japan Friendship Hospital; Beijing Cancer Hospital; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Chinese PLA General Hospital
Not yet recruiting - Condition: Food Allergy
Intervention: Dietary Supplement: Oral immunotherapy
Sponsor: Helsinki University Central Hospital
Recruiting - Condition: Asthma
Interventions: Other: Peak Expiratory Flow Rate (PEFR); Other: Standard Clinical Judgement
Sponsor: Minneapolis Medical Research Foundation
Recruiting - Condition: Chemotherapy Effect
Intervention: Drug: Chemotherapy, Cancer, Anthracyclines
Sponsor: Assiut University
Not yet recruiting - Condition: Dentin Sensitivity
Interventions: Drug: Dentifrice containing 5% w/w KNO3 and 0.454% w/w SnF2 (1100 ppm fluoride).; Drug: Dentifrice containing 0.454% w/w SnF2 (1100 ppm fluoride).
Sponsor: GlaxoSmithKline
Not yet recruiting - Condition: Asthma
Intervention: Other: Asthma Subspecialty Follow-up Visits
Sponsor: Arkansas Children's Hospital Research Institute
Recruiting - Condition: Chemotherapy Effect
Interventions: Other: Stiper; Other: acupuncture; Other: Control
Sponsor: Federal University of São Paulo
Recruiting - Condition: Wheat Allergy
Intervention: Dietary Supplement: Wheat spaghetti
Sponsor: Athens General Children's Hospital "Pan. & Aglaia Kyriakou"
Recruiting - Conditions: Asthma; Healthy
Intervention: Other: Observational
Sponsor: University of Pennsylvania
Recruiting - Condition: Asthma
Interventions: Biological: Tezepelumab; Other: Placebo
Sponsors: AstraZeneca; Amgen
Recruiting - Conditions: Perioperative/Postoperative Complications; Drug-Induced Anaphylaxis
Intervention:
Sponsor: Assiut University
Recruiting - Condition: Food Allergy
Interventions: Behavioral: Behavioral intervention group; Behavioral: Education
Sponsor: Icahn School of Medicine at Mount Sinai
Recruiting - Condition: Peanut Allergy
Intervention: Drug: DBV712 IHRP
Sponsor: DBV Technologies
Recruiting - Condition: Non Alcoholic Steatohepatitis
Interventions: Dietary Supplement: Hesperidin; Other: control
Sponsor: National Nutrition and Food Technology Institute
Recruiting - Condition: Non Alcoholic Steatohepatitis
Interventions: Dietary Supplement: hesperidin and flaxseed; Other: control
Sponsor: National Nutrition and Food Technology Institute
Recruiting - Condition: Atopic Dermatitis
Intervention: Other: narrow-band UVB
Sponsor: Oslo University Hospital
Recruiting - Conditions: Cardiovascular Diseases; Hypertension
Intervention: Drug: Torasemide 5Mg Tablet
Sponsors: NHS Greater Glasgow and Clyde; University of Glasgow; British Heart Foundation
Recruiting - Condition: COPD Asthma
Intervention:
Sponsor: Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Recruiting - Condition: Bronchial Asthma
Interventions: Drug: Fluticasone propionate/salmeterol 100/50 µg; Other: Placebo; Drug: Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUAT
Sponsor: Cipla Ltd.
Not yet recruiting - Condition: Asthma
Interventions: Drug: GSK3772847; Drug: Placebo
Sponsor: GlaxoSmithKline
Recruiting - Condition: Infected Atopic Dermatitis/Eczema
Interventions: Drug: Fucicort® Lipid cream; Drug: Fucidin® cream; Drug: Fucicort® Lipid cream vehicle; Drug: betamethasone (Lianbang Beisong®) cream
Sponsor: LEO Pharma
Recruiting - Condition: Food Allergy
Intervention: Behavioral: mediterranean diet
Sponsor: Federico II University
Recruiting - Condition: Neck Pain
Interventions: Other: Patients with chronic neck pain; Other: Subjects without chronic neck pain
Sponsor: Peking University People's Hospital
Not yet recruiting - Condition: Asthma in Children
Intervention: Other: Nurse-delivered education
Sponsors: University of Rochester; New York State Department of Health
Recruiting - Condition: Prostate Adenocarcinoma
Interventions: Drug: Leuprolide Acetate; Drug: Goserelin Acetate; Radiation: Stereotactic Body Radiation Therapy; Radiation: Radium Ra 223 Dichloride; Other: Laboratory Biomarker Analysis
Sponsor: City of Hope Medical Center
Recruiting - Conditions: Allergic Asthma; Airway Remodelling; Extracellular Matrix Alteration
Interventions: Procedure: Bronchial challenge with allergen; Other: Co-culture formation; Other: Inhibition of Wnt and Smad signaling pathways; Other: Extracellular matrix turnover and deposition assessment; Biological: Dermatophagoides pteronyssinus allergen; Device: Dosimeter ProvoX (Ganshorn); Biological: Eosinophils; Biological: Airway smooth muscle cells; Biological: Fibroblasts
Sponsors: Lithuanian University of Health Sciences; Research Council of Lithuania; University of Groningen
Recruiting - Condition: Atopic Dermatitis (AD)
Interventions: Drug: Dupilumab; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Regeneron Pharmaceuticals; Sanofi; Atopic Dermatitis Research Network
Recruiting - Condition: Asthma
Interventions: Drug: Fluticasone/ Formoterol; Drug: fluticasone/ salmeterol
Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd
Recruiting - Condition: Severe Asthma
Intervention:
Sponsor: AstraZeneca
Recruiting - Condition: Asthma
Interventions: Drug: SAR440340/REGN3500; Drug: Dupilumab; Drug: Fluticasone or Fluticasone/salmeterol combination; Drug: Placebo for SAR440340 (REGN3500); Drug: Placebo for dupilumab
Sponsors: Sanofi; Regeneron Pharmaceuticals
Recruiting - Conditions: Atopic Dermatitis; Effects of Immunotherapy
Interventions: Drug: Mite extract sublingual immunotherapy (SLIT); Other: Placebo
Sponsors: Casa Espirita Terra de Ismael; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - Conditions: Sensitivity; Specificity; Histological Response; Survival
Intervention:
Sponsors: Peking University People's Hospital; Xijing Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting - Condition: Anaphylaxis
Interventions: Combination Product: Epipen 0.3mg; Combination Product: Emerade 300mcg; Combination Product: Emerade 500mcg
Sponsor: Imperial College London
Recruiting - Conditions: Diabetes Mellitus, Type 2; Skeletal Muscle Insulin Sensitivity
Intervention: Drug: Dapagliflozin
Sponsor: AstraZeneca
Recruiting - Conditions: Tuberculosis, Pulmonary; Tuberculosis, Multidrug-Resistant; Tuberculosis, MDR; Tuberculosis; Drug-Resistant Tuberculosis
Interventions: Drug: Pretomanid; Drug: Bedaquiline; Drug: Moxifloxacin; Drug: Pyrazinamide; Drug: HRZE; Drug: HR
Sponsor: Global Alliance for TB Drug Development
Recruiting - Condition: Eosinophilic Esophagitis
Intervention:
Sponsors: Children's Hospital Medical Center, Cincinnati; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Office of Rare Diseases (ORD); National Center for Advancing Translational Science (NCATS)
Not yet recruiting - Condition: Asthma and Allergic Rhinitis
Intervention: Drug: Montelukast 10mg
Sponsor: Clinision
Not yet recruiting - Conditions: Psoriasis; Atopic Dermatitis
Interventions: Drug: BMX-010; Drug: Placebo
Sponsor: BioMimetix JV, LLC
Recruiting - Condition: Non-ST-segment Elevation Myocardial Infarction
Intervention:
Sponsors: Beijing Anzhen Hospital; Beckman Coulter, Inc.
Recruiting - Conditions: Wheezing; Asthma in Children
Intervention:
Sponsors: HUS Skin and Allergy Hospital; Revenio Research; Mehiläinen
Recruiting - Condition: Asthma
Interventions: Drug: FF/UMEC/VI; Drug: FP/SAL; Drug: Tiotropium; Drug: Albuterol/salbutamol; Device: ELLIPTA DPI; Device: DISKUS DPI; Device: RESPIMAT inhaler; Device: Metered Dose Inhaler; Device: Connected Inhaler System
Sponsor: GlaxoSmithKline
Not yet recruiting - Condition: Allergic Conjunctivitis
Interventions: Drug: PR013 (0.045%); Drug: PR013 (0.06%); Drug: Placebo
Sponsor: Realm Therapeutics, Inc.
Recruiting - Conditions: Atopic Keratoconjunctivitis; Vernal Keratoconjunctivitis; Perennial Allergic Conjunctivitis
Intervention: Drug: AK002
Sponsor: Allakos, Inc.
Recruiting - Condition: Atrial Fibrillation
Intervention:
Sponsor: University Hospital Heidelberg
Recruiting - Condition: Behavior, Infant
Interventions: Behavioral: Control; Behavioral: Sensitivity Intervention; Behavioral: Couples' Intervention; Behavioral: Sensitivity and Couples' Intervention
Sponsors: University of Notre Dame; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Conditions: Gait Disorders, Neurologic; Gait Disorder, Sensorimotor
Intervention: Behavioral: Standard locomotor therapy
Sponsors: University of Zurich; Foundation Wings For Life
Recruiting - Conditions: Osteoarthritis, Knee; Pain; Physical Activity; Mitochondrial Pathology
Intervention: Behavioral: Walking
Sponsors: University of Maryland; National Institute of Nursing Research (NINR)
Recruiting - Condition: Atopic Dermatitis
Interventions: Other: TCM; Other: Western medicine
Sponsor: China Medical University Hospital
Recruiting - Condition: Atopic Dermatitis
Intervention: Other: LIPIKAR BAUME AP+ emollient
Sponsors: University of Schleswig-Holstein; Technische Universität Dresden
Recruiting - Condition: Allergic Rhinoconjunctivitis
Interventions: Dietary Supplement: Lertal® + standard therapy; Other: Placebo + standard therapy
Sponsor: NTC srl
Recruiting - Condition: Asthma
Intervention:
Sponsors: AstraZeneca; Parexel; MedImmune LLC
Recruiting - Conditions: Insulin Sensitivity; Endothelial Dysfunction; Blood Pressure
Interventions: Other: High Load/Low Rep Resistance Training; Other: Low Load/High Rep Resistance Training
Sponsor: Arizona State University
Recruiting - Conditions: Chronic Rhinosinusitis (Diagnosis); Asthma; Nasal Polyps
Intervention: Drug: Reslizumab
Sponsor: University of Rochester
Recruiting - Conditions: Asthma; Pediatric ALL
Intervention: Drug: budesonide, beclomethasone
Sponsor: New York City Health and Hospitals Corporation
Recruiting - Condition: Cushing's Disease
Intervention: Other: [11C]-Methionine PET/MRI
Sponsor: Hospices Civils de Lyon
Not yet recruiting - Conditions: Food Allergy; Food Allergy in Infants; Food Allergy in Children; Food Allergen Sensitisation; Milk Allergy; Egg Allergy; Nut Allergy
Intervention: Diagnostic Test: Oral food challenge
Sponsors: King's College London; Guy's and St Thomas' NHS Foundation Trust
Recruiting - Conditions: Prostate Cancer; Bone Metastases
Interventions: Drug: Zoledronic Acid; Drug: Enzalutamide
Sponsor: Azienda Ospedaliera Spedali Civili di Brescia
Recruiting - Condition: Asthma
Interventions: Dietary Supplement: Vitamin D; Dietary Supplement: Placebo
Sponsors: St. Justine's Hospital; Canadian Institutes of Health Research (CIHR); EURO-PHARM International Canada inc.
Not yet recruiting - Condition: Mitochondrial Diseases
Interventions: Drug: Lipitor 20Mg Tablet; Drug: Lipitor 80Mg Tablet; Drug: Placebo Oral Tablet
Sponsors: University of Kansas Medical Center; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - Conditions: Cough; Cough Variant Asthma; Upper-Airway Cough Syndrome; GERD; Allergic Rhinitis
Intervention: Other: Cough variant asthma treatment
Sponsor: Medical University of Warsaw
Recruiting - Condition: PreDiabetes
Interventions: Other: Egg based breakfast foods; Other: Non-egg based breakfast foods
Sponsor: Midwest Center for Metabolic and Cardiovascular Research
Recruiting - Conditions: Celiac Disease; Barrett Esophagus; Gluten Sensitivity; GERD
Intervention: Other: Gluten free diet
Sponsor: McMaster University
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Tralokinumab; Drug: Placebo
Sponsor: LEO Pharma
Recruiting - Condition: Severe Asthma
Intervention:
Sponsor: Medical University of Warsaw
Recruiting - Condition: Allergic Rhinitis
Interventions: Drug: Allergen Immunotherapy Extract; Drug: Allergen Immunotherapy Control
Sponsor: Johns Hopkins University
Recruiting - Conditions: Atopic Dermatitis; Psoriasis
Intervention:
Sponsor: University of Schleswig-Holstein
Recruiting - Conditions: Type2 Diabetes Mellitus; Stable Coronary Artery Disease
Interventions: Drug: Dapagliflozin 10Mg Tab; Other: Placebo
Sponsor: Andrea Giaccari
Recruiting - Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)Condition: Alopecia Areata
Interventions: Drug: Dupilumab; Drug: Placebos
Sponsors: Icahn School of Medicine at Mount Sinai; Rockefeller University
Recruiting - Condition: Asthma
Interventions: Drug: GP MDI 28.8 μg; Drug: GP MDI 14.4 μg; Drug: GP MDI 7.2 μg; Drug: Placebo MDI; Drug: Spiriva Respimat 2.5 μg
Sponsor: Pearl Therapeutics, Inc.
Recruiting - Conditions: Nasal Polyps; Asthma, Aspirin-Induced; Aspirin-exacerbated Respiratory Disease; Aspirin-Sensitive Asthma With Nasal Polyps
Interventions: Drug: Ifetroban; Drug: Placebo
Sponsor: Brigham and Women's Hospital
Recruiting - Condition: Hormone Sensitive Oligometastatic Prostate Cancer
Interventions: Procedure: Radical prostatectomy; Radiation: HDR (19Gy) or SBRT (35-40Gy)
Sponsor: Dr. Patrick Cheung
Recruiting - Conditions: Atopic Dermatitis; Psoriasis
Interventions: Drug: Ustekinumab; Drug: Infliximab; Drug: Secukinumab; Drug: Dupilumab
Sponsor: Prof. Dr. Stephan Weidinger
Recruiting - Condition: Atopic Dermatitis
Intervention: Drug: Crisaborole ointment 2%
Sponsor: Pfizer
Recruiting - Condition: Eosinophilic Esophagitis
Interventions: Device: Cytosponge; Other: Diet; Other: EEsAI Pro; Other: Likert Scoring Scale
Sponsor: Mayo Clinic
Not yet recruiting - Conditions: Acupuncture; Knee Osteoarthritis; Sensitive Acupoints; Tender Points
Intervention: Other: acupuncture
Sponsor: West China Hospital
Not yet recruiting - Condition: Atopic Dermatitis
Intervention: Drug: PR022
Sponsor: Realm Therapeutics, Inc.
Recruiting - Condition: Lymphangioleiomyomatosis
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Allergic Rhinitis
Interventions: Drug: Resveratrol plus Carboxymethyl-β-Glucan; Drug: Placebo
Sponsor: Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Recruiting - Condition: Asthma
Interventions: Biological: Experimental: Tezepelumab; Other: Placebo
Sponsors: AstraZeneca; Amgen
Recruiting - Conditions: African Trypanosomiases; West African; Trypanosomiasis; Sleeping Sickness; West African; Trypanosoma Brucei Gambiense; Infection
Interventions: Diagnostic Test: Rapid diagnostic test (RDT); Diagnostic Test: Serological and molecular tests on DBS
Sponsors: Institut de Recherche pour le Developpement; Ministry of Public Health, Democratic Republic of the Congo; Ministry of Health, Guinea; Institut National de Sante Publique; Institut National de Recherche Biomédicale; CIRDES; Institute of Tropical Medicine, Belgium; University of Liverpool
Recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: PF-04965842 100 mg; Drug: PF-04965842 200 mg; Drug: Placebo
Sponsor: Pfizer
Recruiting - Condition: Healthy
Intervention: Device: rTMS
Sponsor: University of New Mexico
Recruiting - Conditions: Ischemic Stroke; Migraine; Migraine With Aura
Intervention: Other: questionnaire ef-ID Migraine
Sponsor: University Hospital, Montpellier
Recruiting - Condition: Asthma
Interventions: Other: Telephonic interviews; Other: E-RS: COPD; Other: Supplemental asthma items; Other: Daily diary; Other: Sociodemographic questionnaire; Other: Clinical questionnaire
Sponsors: GlaxoSmithKline; Evidera
Recruiting - Conditions: Urticaria; Allergy
Interventions: Drug: IV Dexamethasone; Drug: Oral prednisolone
Sponsor: Chulalongkorn University
Recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: Dupilumab; Drug: Matching placebo
Sponsors: Regeneron Pharmaceuticals; Sanofi
Recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: Dupilumab; Drug: Matching Placebo; Other: Background Treatment: Topical Corticosteroids; Other: Background Treatment: Moisturizers
Sponsors: Regeneron Pharmaceuticals; Sanofi
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Other: Transnasal esophagoscopy
Sponsors: Children's Hospital Medical Center, Cincinnati; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Office of Rare Diseases (ORD); National Center for Advancing Translational Science (NCATS)
Recruiting - Condition: Prediabetes
Interventions: Dietary Supplement: Resistant Starch; Dietary Supplement: Placebo
Sponsor: Hospital de Clinicas de Porto Alegre
Not yet recruiting - Condition: Asthma
Interventions: Dietary Supplement: Probiotical®; Other: Placebo
Sponsors: University Hospital of Liege; European Union
Recruiting - Condition: Rhinitis, Allergic
Interventions: Procedure: Cettum; Procedure: Acupuncture
Sponsors: Eun Jung Kim; DongGuk University
Not yet recruiting - Conditions: Food Allergy; Adherence, Medication
Interventions: Behavioral: Text Message Only; Behavioral: Text message + Incentive 1; Behavioral: Text message + Incentive 2
Sponsors: University of Pennsylvania; Children's Hospital of Philadelphia
Recruiting - Conditions: Allergic Rhinitis; Asthma
Interventions: Drug: Cetirizine Hydrochloride 1 MG/ML; Drug: Placebo - Concentrate
Sponsor: New York City Health and Hospitals Corporation
Recruiting - Condition: Status Asthmaticus
Intervention: Drug: Ketamine
Sponsor: Augusta University
Not yet recruiting - Condition: Chronic Spontaneous Urticaria
Interventions: Drug: Omalizumab; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - Conditions: Adhesion; Thyroidectomy
Intervention: Combination Product: MEDICLORE
Sponsors: Seoul National University Hospital; Daewoong Pharmaceutical Co. LTD.
Recruiting - Conditions: Asthma; Chronic School Absenteeism
Interventions: Behavioral: Home Visit; Behavioral: Standard Care
Sponsor: University of California, Davis
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Baricitinib; Drug: Placebo
Sponsors: Eli Lilly and Company; Incyte Corporation
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Baricitinib; Drug: Placebo
Sponsors: Eli Lilly and Company; Incyte Corporation
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Baricitinib; Drug: Placebo
Sponsors: Eli Lilly and Company; Incyte Corporation
Recruiting - Conditions: Interstitial Lung Disease; Idiopathic Pulmonary Fibrosis; Connective Tissue Related ILD; Chronic Hypersensitivity Pneumonitis; Fibrotic Lung Disease
Interventions: Behavioral: Focus groups; Behavioral: Semi-structured interviews
Sponsors: Kingston University; St. George's Hospital, London; University College London Hospitals
Recruiting - Conditions: Celiac Disease; Wheat Hypersensitivity; Gluten Sensitivity; Gluten Enteropathy; Immune System and Related Disorders; Duodenal Diseases
Interventions: Dietary Supplement: Gluten; Dietary Supplement: Placebo
Sponsor: Mayo Clinic
Recruiting - Condition: Asthma, Exercise-Induced
Intervention: Drug: Benralizumab
Sponsors: Louis-Philippe Boulet; AstraZeneca
Not yet recruiting - Condition: Asthma
Intervention: Device: Feedback using ICT based monitoring system
Sponsors: Yeungnam University Hospital; Ministry of Trade, Industry & Energy, Republic of Korea; Korea Evaluation Institute of Industrial Technology; Daegu Metropolitan City, Korea; ICT Clinical Trial Coordination Center
Recruiting - Conditions: Asthma; Insomnia
Interventions: Behavioral: SHUTi; Behavioral: Emmi
Sponsors: University of Pittsburgh; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Sensitivity
Intervention: Device: Hypoxicator
Sponsor: University of Florida
Recruiting - Condition: Misoprostol Allergy
Intervention: Procedure: office hysteroscopy
Sponsor: Kasr El Aini Hospital
Recruiting - Condition: Breast Cancer
Intervention: Drug: Denosumab Injection
Sponsor: Kyoto Prefectural University of Medicine
Recruiting - Condition: Asthma Brittle
Intervention:
Sponsors: Queen's University, Belfast; RASP (Refractory Asthma Stratification Programme); Medical Research Council; University of Oxford; University of Leicester; NHS Greater Glasgow and Clyde; Belfast Health and Social Care Trust
Recruiting - Condition: Cough Variant Asthma
Intervention: Drug: Chanqin granules
Sponsor: Shanghai University of Traditional Chinese Medicine
Not yet recruiting - Condition: Asthma in Children
Interventions: Behavioral: Reach for Control; Behavioral: MATCH
Sponsors: Wayne State University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Eosinophilic Gastroenteritis
Intervention: Other: elemental diet therapy
Sponsors: Children's Hospital Medical Center, Cincinnati; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Office of Rare Diseases (ORD); National Center for Advancing Translational Science (NCATS)
Recruiting - Condition: Macula Hole
Intervention: Procedure: Macular hole surgery
Sponsor: Central Hospital, Nancy, France
Not yet recruiting - Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: GRASPA
Sponsors: Birgitte Klug Albertsen; ERYtech Pharma
Recruiting - Conditions: Asthma; Emotional Disorder; Alexithymia
Intervention: Other: Interview and tests of drawing.
Sponsor: Hospices Civils de Lyon
Not yet recruiting - Condition: Eosinophilic Esophagitis
Intervention: Diagnostic Test: endoflip
Sponsor: Indiana University
Recruiting - Conditions: Type2 Diabetes; Type 2 Diabetes Mellitus; Insulin Sensitivity; Insulin Resistance; Depression; Adolescent Obesity
Interventions: Behavioral: Cognitive-behavioral therapy group; Behavioral: Health education group
Sponsors: Colorado State University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Advancing Translational Science (NCATS); Children's Hospital Colorado
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Device: Esophageal String Test (EST)
Sponsors: University of Colorado, Denver; Children's Hospital of Philadelphia; Children's Hospital Colorado
Recruiting - Condition: Asthma
Interventions: Other: Compression Stockings; Other: Control
Sponsor: University Health Network, Toronto
Recruiting - Condition: Anaphylaxis
Interventions: Device: Part 1; Device: Part 2 Group 1; Drug: Part 2 group 2; Device: Part 2 group 3; Device: Part 2 Group 4
Sponsor: Bausch & Lomb Incorporated
Recruiting - Condition: Chronic Urticaria
Intervention:
Sponsor: Ajou University School of Medicine
Recruiting - Condition: Bronchial Asthma
Interventions: Drug: Jia Wei Yang He granule; Drug: Jia Wei Yang He granule Placebo
Sponsors: Shanghai University of Traditional Chinese Medicine; Fudan University
Recruiting - Conditions: Asthma; Compliance, Patient; Quality of Life
Intervention:
Sponsor: Elpen Pharmaceutical Co. Inc.
Recruiting - Condition: Asthma
Interventions: Behavioral: BREATHE Intervention; Behavioral: Control Intervention
Sponsor: Columbia University
Recruiting - Condition: Asthma
Interventions: Drug: CJM112; Other: Placebo to CJM112
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Asthma
Interventions: Behavioral: School; Behavioral: Asthma education; Behavioral: Home environmental remediation; Behavioral: Informational mail
Sponsors: Virginia Commonwealth University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Colorectal Cancer Metastatic
Intervention: Drug: Based on sensitivity analysis
Sponsor: Vejle Hospital
Recruiting - Conditions: Asthma Acute; Asthma in Children
Interventions: Device: BiPAP; Device: CPAP; Drug: Ipratropium; Drug: Magnesium Sulfate; Drug: Aminophylline; Drug: Standard steroid dose, hourly salbutamol, oxygen as needed
Sponsors: University of British Columbia; Post Graduate Institute of Medical Education and Research, Chandigarh
Not yet recruiting - Condition: Cow Milk Allergy
Interventions: Other: Test extensively hydrolyzed formula; Other: Control extensively hydrolyzed formula
Sponsor: Nestlé
Recruiting - Condition: Asthma
Intervention: Behavioral: High Intensity Interval Training
Sponsor: Bispebjerg Hospital
Recruiting - Condition: Asthma
Intervention: Behavioral: Weight loss intervention
Sponsors: Johns Hopkins University; American Lung Association; National Heart, Lung, and Blood Institute (NHLBI); University of Vermont; University of Arizona
Recruiting - Condition: Asthma
Interventions: Biological: Mepolizumab; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Inner-City Asthma Consortium; GlaxoSmithKline
Recruiting - Conditions: Atopic Dermatitis; Atopic Dermatitis Eczema
Intervention: Drug: Dupilumab
Sponsors: University of California, San Francisco; Regeneron Pharmaceuticals
Not yet recruiting - Condition: Eosinophilic Esophagitis
Interventions: Diagnostic Test: Barium Esophagram; Device: EsophaCap; Diagnostic Test: Physical Examination and Questionnaires
Sponsor: Mayo Clinic
Recruiting - Conditions: Allergic Rhinitis; Allergic Rhinitis Due to Grass Pollen; Healthy Volunteers
Interventions: Biological: B244 suspension; Biological: Vehicle
Sponsors: AOBiome LLC; Orange County Research Center; Integrium
Recruiting - Conditions: Dysphagia; Stroke
Interventions: Diagnostic Test: FEES (flexible endoscopic evaluation of swallowing); Other: Sensitivity threshold; Diagnostic Test: Taste-/smell-test; Diagnostic Test: Neuropsychological testing
Sponsor: University of Giessen
Recruiting - Condition: Asthma
Interventions: Drug: GSK3511294; Drug: Placebo; Drug: Salbutamol/albuterol
Sponsor: GlaxoSmithKline
Recruiting - Conditions: Rhinitis; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal; Rhinitis, Allergic, Perennial
Intervention:
Sponsor: Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Recruiting - Condition: Cow Milk Allergy
Intervention:
Sponsor: Ankara University
Recruiting - Conditions: Irritable Bowel Syndrome; Visceral Hypersensitivity
Interventions: Device: Rapid Barostat Bag; Other: IBS severity scoring system questionnaire (IBS-SSS); Other: HAD scale questionnaire
Sponsor: Queen's University
Recruiting - Condition: Diabetes
Interventions: Drug: Continous IV infusion of Nesiritide; Drug: Hyperinsulinemic euglycemic clamp; Drug: Placebo
Sponsor: Translational Research Institute for Metabolism and Diabetes, Florida
Recruiting - Conditions: Apnea; Respiration Disorder
Intervention: Device: Pressure sensitive mat
Sponsors: Children's Hospital of Eastern Ontario; NSERC Collaborative Research and Development
Recruiting - Conditions: Prostate Cancer; Prostate Adenocarcinoma
Intervention: Drug: ADT+Docetaxel+Enzalutamide
Sponsors: Earle Burgess; Astellas Pharma Inc; Medivation, Inc.
Recruiting - Condition: Sepsis, Severe
Intervention: Other: no intervention
Sponsors: Medical University of Graz; Dalian Medical University
Recruiting - Conditions: Asthma; Allergic Rhinitis
Intervention:
Sponsor: Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Recruiting - Conditions: Asthma; Status; Asthma in Children; Asthma Acute; Asthma Attack; Acute Asthma Exacerbation
Intervention: Drug: Montelukast Oral Granules
Sponsor: Vanderbilt University Medical Center
Not yet recruiting - Condition: Asthma
Interventions: Device: DragONE; Device: SmartOne
Sponsor: Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Recruiting - Condition: Asthma
Intervention: Drug: Fluticasone propionate
Sponsor: GlaxoSmithKline
Recruiting - Conditions: COPD; Asthma
Intervention: Other: No intervention
Sponsor: Chinese University of Hong Kong
Recruiting - Conditions: PreDiabetes; Body Weight
Interventions: Drug: Empagliflozin 25mg; Drug: Placebo Oral Tablet
Sponsor: University Hospital Tuebingen
Recruiting - Conditions: Rheumatologic Disorder; Inflammatory Bowel Diseases; Immune Complex Diseases
Intervention: Biological: Influenza vaccine
Sponsors: Stony Brook University; University of North Carolina, Chapel Hill
Recruiting - Condition: Glucose Intolerance
Intervention: Drug: Carnitene (L-Carnitine or Levocarnitine)
Sponsor: Maastricht University Medical Center
Recruiting - Condition: Atopic Dermatitis
Interventions: Biological: FURESTEM-AD Inj.; Other: Placebo
Sponsor: Kang Stem Biotech Co., Ltd.
Recruiting - Condition: Atopic Eczema
Intervention: Device: Domestic ion-exchange water softener
Sponsors: King's College London; Guy's and St Thomas' NHS Foundation Trust; University of Nottingham; University of Sheffield; Imperial College London; University of Amsterdam; University of Dundee
Recruiting - Condition: Asthma
Interventions: Behavioral: ACTION Intervention; Other: Enhanced usual care
Sponsor: University of Illinois at Chicago
Recruiting - Condition: Asthma
Interventions: Biological: PCV13; Biological: PPSV23
Sponsor: Mayo Clinic
Recruiting - Condition: Deafness, Bilateral
Interventions: Behavioral: Parent-Child Early Approaches to Raising Language Skills; Other: Standard Care Speech therapy
Sponsors: University of Miami; National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - Condition: Atopic Dermatitis
Intervention: Drug: INCB018424 phosphate cream
Sponsor: Incyte Corporation
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Stoss vitamin D; Drug: Daily vitamin D; Drug: Stoss placebo; Drug: Daily placebo
Sponsor: Murdoch Childrens Research Institute
Recruiting - Condition: Mild to Moderate Atopic Dermatitis
Interventions: Behavioral: Online Treatment response; Drug: EUCRISA
Sponsor: Wake Forest University Health Sciences
Recruiting - Condition: Asthma
Interventions: Drug: FF/VI via ELLIPTA DPI; Drug: FF via ELLIPTA DPI
Sponsor: GlaxoSmithKline
Recruiting - Conditions: Neuropathy, Painful; Chemotherapy-induced Peripheral Neuropathy; Colorectal Cancer
Interventions: Drug: Lidocaine Hydrochloride; Drug: Placebo; Drug: FOLFOX regimen
Sponsor: Washington University School of Medicine
Recruiting - Condition: Overweight
Interventions: Other: High dose vegetable juice; Other: Medium dose vegetable juice; Other: Low dose vegetable juice; Other: Control bottled water
Sponsor: USDA Grand Forks Human Nutrition Research Center
Recruiting - Condition: Nonceliac Gluten Sensitivity
Intervention: Diagnostic Test: Gluten or placebo capsules
Sponsor: Antonio Di Sabatino
Recruiting - Condition: Eosinophilic Esophagitis (EoE)
Intervention: Drug: Budesonide oral suspension
Sponsor: Shire
Recruiting - Conditions: Sensory Disorders; Autism; Autism Spectrum Disorder; Autism With High Cognitive Abilities; Autistic Behavior; Hyperacusis
Interventions: Behavioral: Exposure therapy; Behavioral: Psycho-education; Behavioral: Caregiver education/home program development
Sponsor: University of Florida
Recruiting - Condition: Asthma
Intervention: Other: asthmatic exacerbation
Sponsor: Chinese University of Hong Kong
Recruiting - Condition: Dentine Hypersensitivity
Interventions: Drug: 5% fluoride varnish; Drug: 8% arginine containing paste; Drug: Self-adhesive resin
Sponsor: Aga Khan University
Recruiting - Condition: Hereditary Angioedema (HAE)
Interventions: Drug: BCX7353; Drug: Placebo
Sponsor: BioCryst Pharmaceuticals
Recruiting - Condition: Rheumatoid Arthritis
Interventions: Drug: Evobrutinib; Drug: Placebo; Drug: Methotrexate
Sponsors: EMD Serono Research & Development Institute, Inc.; Merck KGaA
Recruiting - Condition: Atopic Dermatitis Eczema
Interventions: Biological: B244; Biological: Vehicle
Sponsors: AOBiome LLC; Veristat, Inc.
Recruiting - Condition: Obesity
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: Lung Diseases
Interventions: Other: functional Magnetic Resonance Imaging (research grade); Other: Cognitive Function Testing (non-diagnostic); Other: Asthma and Psychological Questionnaires (non-diagnostic)
Sponsors: University of Wisconsin, Madison; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Metastatic Breast Cancer
Interventions: Drug: Palbociclib; Drug: Endocrine therapy (non IMP)
Sponsor: MedSIR
Recruiting - Condition: Bronchial Asthma
Interventions: Drug: Ke Chuan Liu Wei Granule; Drug: Yang He Ping Chuan Granule; Other: Ke Chuan Liu Wei Granule placebo; Other: Yang He Ping Chuan Granule placebo
Sponsors: Shanghai University of Traditional Chinese Medicine; Longhua Hospital
Not yet recruiting - Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal IntConditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
Interventions: Biological: FATE-NK100; Drug: Interleukin-2
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting - Conditions: Anxiety Disorders and Symptoms; Depression
Interventions: Behavioral: Social Approach Training (5 sessions); Behavioral: Social Approach Training (10 sessions)
Sponsor: University of California, San Diego
Recruiting - Condition: Asthma
Interventions: Drug: QAW039; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - Conditions: Schizophrenia; Gluten Sensitivity; Schizo Affective Disorder
Interventions: Other: Gluten Flour in Protein Shake; Other: Rice Flour in Protein Shake
Sponsor: University of Maryland
Recruiting - Condition: Stress Disorders, Post-Traumatic
Intervention: Device: HIRREM
Sponsors: Wake Forest University Health Sciences; Brain State Technologies, LLC
Recruiting - Conditions: Depression; Anxiety; Somatoform Disorders; Alcohol Abuse
Intervention:
Sponsors: Charite University, Berlin, Germany; German Federal Ministry of Education and Research
Recruiting - Conditions: Antibiotic Side Effect; Eyelid; Wound; Eyelid Diseases; Surgical Wound Infection; Surgical Wound, Recent; Surgical Incision; Skin Cancer Face; Antibiotic Allergy; Surgical Site Infection
Interventions: Drug: Topical Anti-Infective Product; Drug: Topical Ointment
Sponsor: University of California, San Francisco
Recruiting - Condition: Asthma
Interventions: Drug: QAW039; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - Conditions: Quality of Life; Ovarian Cancer; Recurrent Ovarian Carcinoma
Intervention: Other: no intervention - observational study
Sponsor: North Eastern Germany Society of Gynaecologic Oncology
Recruiting - Condition: Glucose Metabolism Disorders
Interventions: Drug: Melatonin; Other: Placebo
Sponsors: University of Aarhus; University of Copenhagen
Recruiting - Condition: Asthma
Interventions: Drug: GSK3772847; Drug: Placebo; Drug: Fluticasone propionate/salmeterol; Drug: Fluticasone propionate
Sponsor: GlaxoSmithKline
Recruiting - Adiponectin, IL-6 and hsC-RP in Relation to Carotid Intima-media Thickness in B-thalassemia PatientsCondition: Thalassemia
Interventions: Diagnostic Test: Interleukin-6; Diagnostic Test: HsC-RP; Diagnostic Test: Adiponectin level; Diagnostic Test: Carotid intima media thickness
Sponsor: Assiut University
Not yet recruiting - Conditions: Heart Diseases; Coronary Disease; Coronary Artery Disease; Cardiovascular Diseases; Myocardial Ischemia; Artery Occlusion; Aspirin Sensitivity; Clopidogrel, Poor Metabolism of; Platelet Dysfunction; Platelet Thrombus
Interventions: Drug: Clopidogrel; Drug: Aspirin
Sponsor: University of Maryland
Not yet recruiting - Conditions: Hypertension Uncomplicated; Pre Hypertension
Intervention: Diagnostic Test: High and low salt diets
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - Conditions: Conjunctivitis, Allergic; Conjunctivitis, Vernal
Interventions: Drug: Hyaluronic acid 0.05% & Ectoine 2.0%; Drug: Olopatadine hydrochloride ophthalmic solution 0.1%
Sponsors: Michael Marchand, MD; Université de Montréal
Recruiting - Conditions: Diabetes Mellitus, Type II; Insulin Resistance
Interventions: Procedure: HBO; Procedure: Hyperbaric air
Sponsors: University of Adelaide; Royal Adelaide Hospital
Recruiting - Condition: Asthma
Intervention: Other: Electronic Asthma Management System: eAMS
Sponsors: St. Michael's Hospital, Toronto; Ontario Lung Association
Not yet recruiting - Condition: Chronic Idiopathic Urticaria
Interventions: Biological: benralizumab; Biological: placebo
Sponsor: Jonathan A. Bernstein, MD
Recruiting - Condition: Outcome After Total Knee Arthroplasty
Intervention: Procedure: total knee arthroplasty
Sponsors: University of Salford; Stockport NHS Foundation Trust
Not yet recruiting - Condition: Asthma
Interventions: Biological: Benralizumab; Biological: Placebo
Sponsor: AstraZeneca
Recruiting - Condition: Atopic Dermatitis
Interventions: Other: CeraVe® Eczema Soothing Body Wash; Other: Cetaphil® RestoraDerm® Eczema Calming Body Wash; Other: Dove® Sensitive Skin Body Wash; Other: Eucerin® Skin Calming Body Wash; Other: Aveeno® Skin Relief Body Wash; Other: MooGoo® Milk Wash; Other: Free & Clear Liquid Cleanser
Sponsor: University of Arizona
Recruiting - Condition: Asthma
Interventions: Drug: Benralizumab (Medi-563); Drug: Placebo
Sponsor: AstraZeneca
Recruiting - Condition: Dermatitis, Atopic
Interventions: Dietary Supplement: PREBIOTICS; Other: PLACEBO
Sponsor: Nantes University Hospital
Recruiting - Condition: Advanced Malignant Neoplasm
Interventions: Dietary Supplement: Fat Emulsion; Other: Placebo
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting - Condition: Triple Negative Breast Cancer
Interventions: Drug: Olaparib Oral Product; Drug: Olaparib Oral Product in combination with Durvalumab
Sponsors: Duke University; AstraZeneca
Not yet recruiting - Conditions: Scheduled Surgery; Healthy Volunteers
Intervention: Behavioral: Psychophysical exploration
Sponsors: University Hospital, Clermont-Ferrand; Inserm U1107 « Neuro-Dol », Clermont-Ferrand, France; Centre Jean Perrin; Klinikum der Universität München, Deutschland
Recruiting - Conditions: Atopic Dermatitis; Eczema, Atopic
Interventions: Drug: ALX-101 Gel 1.5% and ALX-101 Gel Vehicle; Drug: ALX-101 Gel 5% and ALX-101 Gel Vehicle
Sponsor: Ralexar Therapeutics, Inc.
Recruiting - Condition: Allergy; Dander
Interventions: Diagnostic Test: Male dog; Diagnostic Test: Female dog
Sponsor: Copenhagen Studies on Asthma in Childhood
Recruiting - Conditions: Obesity; Insulin Resistance; Type2 Diabetes
Intervention:
Sponsors: University of Colorado, Denver; National Institutes of Health (NIH); Children's Hospital Colorado
Recruiting - Condition: Orthopaedic Trauma Infections
Intervention: Diagnostic Test: Highly Sensitive Assays
Sponsor: University of Maryland
Recruiting - Condition: Urticaria Chronic
Intervention:
Sponsor: HaEmek Medical Center, Israel
Recruiting - Condition: Asthma
Interventions: Drug: QVM149; Drug: Salmeterol/fluticasone plus tiotropium
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Status Asthmaticus
Interventions: Device: HFNC; Device: Standard Oxygen Treatment
Sponsor: Hospices Civils de Lyon
Recruiting - Efficacy and Safety of Ojeok-san on Korean Patients With Cold Hypersensitivity in the Hands and FeetCondition: Cold Hypersensitivity
Interventions: Drug: Ojeok-San; Drug: Placebo
Sponsors: Chan-Yong Jeon; Kyunghee University Oriental Medical Center; Kyung Hee University Hospital at Gangdong; Semyung University second affiliated oriental medical hospital at Chungju
Recruiting - Condition: Atopic Dermatitis (AD)
Interventions: Biological: TMT Lotion; Drug: Placebo Lotion
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Atopic Dermatitis Research Network
Recruiting - Condition: Cow's Milk Protein Allergy
Interventions: Other: Test infant formula with HMOs; Other: Control infant formula without HMOs
Sponsor: Nestlé
Recruiting - Condition: Urticaria
Interventions: Drug: GDC-0853; Drug: Placebo
Sponsor: Genentech, Inc.
Recruiting - Conditions: Acute Coronary Syndrome; Chest Pain
Intervention: Diagnostic Test: Coronary CT Angiography
Sponsor: Admir Dedic
Recruiting - Condition: Unilateral Cerebral Palsy
Intervention: Other: Measurement of maximal forces of elbow pronosupination and flexion-extension
Sponsor: Nantes University Hospital
Recruiting - Condition: Atopic Eczema
Intervention: Diagnostic Test: Skin Testing for Atopic eczema
Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; University of Sheffield
Recruiting - Condition: Asthma
Intervention: Other: Tapering of ICS treatment
Sponsor: Hvidovre University Hospital
Not yet recruiting - Condition: Knee Osteoarthritis
Intervention: Drug: Blinded study medication
Sponsor: Johns Hopkins University
Recruiting - Condition: Asthma
Interventions: Drug: CSJ117; Drug: Placebo Comparator
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Psoriasis
Intervention: Other: 12-week elimination diet
Sponsor: University of Michigan
Recruiting - Condition: Asthma
Intervention: Biological: hMSCs
Sponsor: Marilyn Glassberg
Recruiting - Condition: COPD Asthma
Interventions: Device: Spirometry; Drug: Albuterol
Sponsors: University of Illinois at Chicago; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - Condition: Asthma
Interventions: Other: Questionnaire; Other: Software of Big Data
Sponsors: GlaxoSmithKline; Quintiles IMS
Recruiting - Condition: Asthma in Children
Intervention: Drug: Inhaled corticosteroid (mometasone)
Sponsors: University of Pittsburgh; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Conditions: Allergy; Asthma; Urticaria
Intervention:
Sponsor: University of Nebraska
Recruiting - Conditions: Diabetes Mellitus, Type 1; Gastroparesis; Dyspepsia; Gluten Sensitivity
Intervention: Other: Gluten-free diet
Sponsor: McMaster University
Recruiting - Condition: Asthma
Interventions: Drug: Dexamethasone; Drug: Prednisone
Sponsor: Children's Hospital of Eastern Ontario
Recruiting - Conditions: HIV; Insulin Sensitivity; Diabetes Mellitus
Interventions: Drug: Zidovudine; Drug: Nevirapine
Sponsors: Ann & Robert H Lurie Children's Hospital of Chicago; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: Dysfunctional Breathing in Asthma
Interventions: Other: Breathing Exercises; Other: Usual care
Sponsors: Naestved Hospital; Zealand University Hospital; Hvidovre University Hospital; Aalborg Universitetshospital; Bispebjerg Hospital; TrygFonden, Denmark; Slagelse Hospital; Region Zealand; Association of Danish Physiotherapists; Allergi og Lungeklinikken Helsingør
Recruiting - Condition: Perennial Allergic Rhinitis
Intervention: Drug: Acarovac
Sponsors: University Hospital of Cologne; Bencard Allergie GmbH
Recruiting - Condition: Urticaria Chronic
Intervention: Drug: Omalizumab
Sponsors: Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Immunity
Interventions: Other: Infant formula with added synbiotics; Other: Standard infant formula
Sponsor: Nutricia Research
Recruiting - Condition: Asthma
Intervention: Drug: QMF149
Sponsor: Novartis Pharmaceuticals
Recruiting - Conditions: African Trypanosomiasis; African; Trypanosomiasis, West; Sleeping Sickness; West African; Trypanosoma Brucei Gambiense; Infection
Intervention: Diagnostic Test: RNA and neopterin detection
Sponsors: Institut de Recherche pour le Developpement; Institute of Tropical Medicine, Belgium; Institut National de Recherche Biomédicale; Ministry of Public Health, Democratic Republic of the Congo
Recruiting - Condition: Asthma, Allergic
Interventions: Drug: REGN3500; Drug: Dupilumab; Drug: Placebo; Drug: Fluticasone propionate
Sponsors: Regeneron Pharmaceuticals; Sanofi
Recruiting - Condition: Immunity
Interventions: Other: Infant Formula with added synbiotics; Other: Standard Infant formula
Sponsor: Nutricia Research
Not yet recruiting - Condition: Diabetes
Intervention: Other: Training or detraining
Sponsors: University of Aberdeen; NHS Grampian
Recruiting - Conditions: Asthma; Cough; Cough Variant Asthma
Interventions: Drug: Methacholine (MCh) Challenge Testing; Diagnostic Test: Eucapneic Voluntary Hyperventilation (EVH) and Hypertonic Saline (HS) Challenge Tests
Sponsor: Queen's University
Not yet recruiting - Conditions: Obesity; Adolescent Development; Pregnancy Related; Insulin Sensitivity; Interpersonal Relations; Stress
Interventions: Behavioral: Interpersonal Psychotherapy; Behavioral: Treatment-as-usual
Sponsors: Colorado State University; University of Colorado, Denver; Children's Hospital Colorado
Recruiting - Condition: Avian Hypersensitivity Pneumonitis
Interventions: Other: additional blood sample; Other: respiratory functional exploration
Sponsor: Centre Hospitalier Universitaire de Besancon
Recruiting - Condition: Amblyopia
Interventions: Drug: Donepezil; Behavioral: Single-letter training; Behavioral: Uncrowd training
Sponsor: Dennis Levi
Recruiting - Conditions: Asthma Attack; Emergency Medicine
Intervention: Other: completion of self-reported questionnaires
Sponsors: Olivier CHASSANY; EA 7334, Patient-Centered Outcomes Research; Bichat Hospital; Beaujon Hospital
Recruiting - Conditions: Staphylococcus Aureus Bacteremia; Anti-Bacterial Agents
Interventions: Biological: N-Rephasin® SAL200; Other: Placebo
Sponsor: Intron Biotechnology, Inc.
Recruiting - Condition: LRTI
Intervention: Device: PCT Arm
Sponsor: Johns Hopkins University
Recruiting - Conditions: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Carcinoma
Interventions: Drug: ribociclib; Drug: Paclitaxel; Drug: Carboplatin
Sponsor: Ronald Buckanovich
Recruiting - Conditions: Metabolic Syndrome; Physical Activity; Insulin Resistance; Cardiovascular Diseases
Intervention: Behavioral: Reduced sitting
Sponsors: Turku University Hospital; UKK Institute
Recruiting - Condition: Lymphoma
Intervention: Drug: Revlimid
Sponsor: Celgene
Recruiting - Condition: Posttraumatic Stress Disorder
Interventions: Biological: Typhoid Vi Polysaccharide Vaccine; Biological: Placebo
Sponsors: University of California, San Francisco; National Institute of Mental Health (NIMH)
Not yet recruiting - Condition: Asthma
Interventions: Diagnostic Test: Magnetic Resonance Imaging (MRI) with Ultrashort Echo Time (UTE); Diagnostic Test: Computed tomography (CT)
Sponsor: University Hospital, Bordeaux
Recruiting - Condition: Non-celiac Wheat Sensitivity
Intervention: Other: Gluten free diet
Sponsor: University of Palermo
Recruiting - Condition: Atopic Dermatitis
Intervention: Other: Narrow band UVB treatment (NB-UVB)
Sponsor: Rockefeller University
Recruiting - Condition: Non-celiac Wheat Sensitivity
Interventions: Dietary Supplement: Wheat flour; Dietary Supplement: Placebo
Sponsor: University of Palermo
Recruiting - Condition: Non-celiac Wheat Sensitivity
Intervention: Other: Gluten free diet
Sponsor: University of Palermo
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Device: swallowed sponge device
Sponsor: Mayo Clinic
Recruiting - Condition: Peanut Allergy
Intervention: Other: Peanut in diet
Sponsors: Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID); Massachusetts General Hospital
Recruiting - Condition: Allergic Rhinitis
Intervention: Other: Self Questionnaire
Sponsor: University Hospital, Montpellier
Recruiting - Condition: Healthy Subjects
Interventions: Other: Aldosterone response to AngII LS; Other: Renal blood flow response to salt; Other: Vascular Stiffness
Sponsor: Brigham and Women's Hospital
Recruiting - Conditions: Insulin Sensitivity; Insulin Resistance; Type 2 Diabetes Mellitus
Intervention: Dietary Supplement: Yakult light
Sponsors: Loughborough University; Yakult Honsha Co., LTD
Recruiting - Condition: Colon Carcinoma
Interventions: Drug: Nivolumab; Drug: Ipilimumab; Drug: Celecoxib 200mg
Sponsors: The Netherlands Cancer Institute; Bristol-Myers Squibb
Recruiting - Condition: Non-celiac Wheat Sensitivity
Interventions: Other: Lactose breath test; Other: DBPC cow's milk protein challenge
Sponsor: University of Palermo
Recruiting - Condition: Asthma Childhood
Intervention: Behavioral: PRAGMATIC
Sponsors: Montefiore Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Asthma
Interventions: Drug: QVM149 150/50/80 μg o.d.; Drug: QVM149 150/50/160 μg o.d.; Drug: salmeterol/fluticasone FDC 50/500 μg b.i.d.
Sponsor: Novartis Pharmaceuticals
Recruiting - Conditions: Retinoblastoma; Cataracts Infantile; Glaucoma, Congenital; Leucocoria
Interventions: Other: CRADLE; Other: Red reflex testing
Sponsor: St. Jude Children's Research Hospital
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: IDP-124 Lotion; Drug: IDP-124 Vehicle Lotion
Sponsor: Valeant Pharmaceuticals International, Inc.
Not yet recruiting - Conditions: Physical Inactivity; Dietary Protein
Intervention: Behavioral: activity level
Sponsors: University of Missouri-Columbia; American Egg Board
Recruiting - Condition: Moderate-to-severe Atopic Dermatitis
Intervention: Other: No study intervention
Sponsor: Technische Universität Dresden
Recruiting - Condition: Asthma
Interventions: Drug: C1-inhibitor; Other: Saline; Drug: Antibiotics
Sponsors: T. van der Poll; ZonMw: The Netherlands Organisation for Health Research and Development; Sanquin
Recruiting - Condition: Asthma
Interventions: Drug: QAW039 Dose 1; Drug: QAW039 Dose 2; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Severe Atopic Dermatitis
Interventions: Other: Polyethylene glycol hexadecyl ether & Betamethasone valerate cream 0.1%; Other: Fusidic acid, polyethylene glycol hexadecyl ether & Betamethasone valerate cream 0.1%
Sponsor: Red Cross War Memorial Childrens Hospital
Not yet recruiting - Condition: Peanut Allergy
Intervention: Biological: AR101
Sponsor: Aimmune Therapeutics, Inc.
Recruiting - Conditions: Atopic Dermatitis; Ichthyosis; Psoriasis
Interventions: Other: Itch Questionnaire and Interview; Other: Stigma Questionnaire and Interview; Other: Cognitive Interview and PROMIS Itch Questionnaire
Sponsor: Northwestern University
Recruiting - Condition: Peanut Allergy
Interventions: Biological: HAL-MPE1; Drug: HAL-MPE1 placebo
Sponsor: HAL Allergy
Recruiting - Condition: Soft Tissue Sarcoma Adult
Interventions: Drug: Multiple drug microinjection; Device: CIVO device
Sponsors: Presage Biosciences; Fred Hutchinson Cancer Research Center; University of Washington; Northwell Health
Recruiting - Conditions: Stress Urinary Incontinence; Pelvic Organ Prolapse
Intervention: Procedure: Urodynamics
Sponsor: The Cleveland Clinic
Recruiting - Condition: Effect of Magnesium in Diabetes
Interventions: Dietary Supplement: Magnesium citrate; Dietary Supplement: Placebo
Sponsor: Protina Pharmazeutische GmbH
Recruiting - Condition: Allergic Rhinitis
Interventions: Drug: Bu-Zhong-Yi-Qi-Tang; Drug: placebo
Sponsor: Chang Gung Memorial Hospital
Recruiting - Conditions: ASTHMA; ANXIETY
Intervention: Behavioral: heart rate variability biofeedback
Sponsor: Rutgers, The State University of New Jersey
Not yet recruiting - Condition: Asthma Exacerbation
Interventions: Device: Aeroneb nebulizer; Device: Small volume jet nebulizer
Sponsor: Tufts Medical Center
Recruiting - Condition: Asthma, Aspirin-Induced
Interventions: Drug: Ifetroban Oral Capsule; Drug: Placebo Oral Capsule
Sponsor: Cumberland Pharmaceuticals
Recruiting - Condition: Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
Intervention: Drug: OLAPARIB
Sponsor: AstraZeneca
Recruiting - Conditions: Platinum Sensitive Ovarian Cancer; Ovarian Cancer
Interventions: Biological: FRα peptide plus Adjuvant (GM-CSF); Drug: Adjuvant (GM-CSF) Alone
Sponsor: Tapimmune Inc.
Recruiting - Conditions: Acute Coronary Syndrome; Chest Pain
Interventions: Procedure: Blood Sample; Behavioral: HEART Score
Sponsors: University of Florida; Roche Diagnostics
Recruiting - Condition: Inflammatory Back Pain
Intervention: Other: Gluten free diet
Sponsor: University of Palermo
Not yet recruiting - Condition: Insulin Resistance
Interventions: Other: nasal insulin; Other: placebo spray
Sponsor: University Hospital Tuebingen
Recruiting - Conditions: Insulin Sensitivity; Obesity; Sedentary Lifestyle
Intervention: Behavioral: Exercise
Sponsor: Oregon State University
Recruiting - Condition: Hemoperitoneum
Intervention: Procedure: Fast exam
Sponsor: The Guthrie Clinic
Recruiting - Condition: Atopic Dermatitis
Intervention: Biological: Roseomonas mucosa
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Asthma; Gastroesophageal Reflux
Interventions: Drug: commercially available lansoprazole; Drug: matched placebo
Sponsors: Jason Lang, M.D., M.P.H.; Thrasher Research Fund; Nemours Children's Clinic
Recruiting - Conditions: Sinusitis; Asthma
Interventions: Drug: Mometasone Nasal; Drug: placebo mometasone
Sponsor: Medical Universtity of Lodz
Recruiting - Condition: Peanut Allergy
Intervention: Biological: Fecal Microbiota Capsule
Sponsor: Rima Rachid
Recruiting - Conditions: Type2 Diabetes; Weight Loss; Insulin Sensitivity; Metabolism and Nutrition Disorder; Metabolism Disorder, Glucose; Bariatric Surgery Candidate
Interventions: Procedure: Gastric by-pass surgery; Dietary Supplement: Low-caloric diet
Sponsors: Uppsala University; AstraZeneca
Recruiting - Condition: Interstitial Lung Disease
Interventions: Drug: Pirfenidone; Other: Placebo controlled
Sponsors: National Jewish Health; Genentech, Inc.
Recruiting - Conditions: Type 1 Diabetes Mellitus; Maturity-Onset Diabetes of the Young, Type 2; MODY2; Insulin Resistance
Interventions: Drug: Hyperinsulinemic, euglycemic clamp; Drug: 20% dextrose
Sponsor: Vanderbilt University
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: IDP-124 Lotion; Drug: IDP-124 Vehicle Lotion
Sponsor: Valeant Pharmaceuticals International, Inc.
Recruiting - Conditions: Asthma in Children; Humans; Hispanic Americans; Child
Interventions: Device: SmartInhaler with reminder function turned on; Device: SmartInhaler
Sponsors: University of California, San Francisco; Academic Pediatric Association
Recruiting - Conditions: Insulin Sensitivity; Type2 Diabetes
Interventions: Behavioral: Increased dairy product; Behavioral: Dietary counselling
Sponsors: CHU de Quebec-Universite Laval; Canadian Institutes of Health Research (CIHR)
Recruiting - Condition: Tuberculosis
Interventions: Drug: Everolimus 0.5 MG; Drug: Auranofin 6 MG; Drug: Vitamin D3; Drug: CC-11050; Drug: 2HRbZE/4HRb
Sponsor: The Aurum Institute NPC
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: SAN007 Cream; Drug: Placebo
Sponsors: Santalis Pharmaceuticals, Inc.; ClinDatrix, Inc.; Fremantle Dermatology
Not yet recruiting - Conditions: Asthma, Allergic; Rhinitis,Allergic; Allergy
Interventions: Drug: Azelastine-Fluticasone Nasal; Drug: Placebos
Sponsor: University of Dundee
Recruiting - Condition: Asthma
Intervention: Drug: PARTICS using QVAR
Sponsors: Brigham and Women's Hospital; Patient-Centered Outcomes Research Institute; American Academy of Family Physicians
Recruiting - Condition: Abdominal Obesity Metabolic Syndrome
Interventions: Dietary Supplement: Pyridoxamine; Dietary Supplement: Placebo
Sponsors: Maastricht University Medical Center; Top Institute Food and Nutrition; Center for Translational Molecular Medicine
Recruiting - Conditions: Eosinophilic Esophagitis; Healthy
Intervention: Device: Mucosal Impedance Balloon catheter
Sponsors: Mayo Clinic; Sandhill Scientific
Recruiting - Conditions: Breast Cancer; Breast Neoplasms
Intervention: Behavioral: Social support intervention
Sponsors: University of Houston; University of California, Los Angeles; Herald Cancer Association; National Cancer Institute (NCI)
Recruiting - Conditions: Overweight; Obesity; Insulin Resistance
Interventions: Other: Plant-based diet; Other: Control Diet
Sponsors: Physicians Committee for Responsible Medicine; Yale University
Recruiting - Condition: Carcinomatous or Polymorphous Skin Lesions
Intervention: Device: bimodal optical spectroscopy
Sponsors: Centre Hospitalier Régional Metz-Thionville; University of Lorraine
Recruiting - Condition: Asthma
Interventions: Drug: Fp MDPI; Drug: FS MDPI; Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting - Conditions: BRCA1 Gene Mutation; BRCA2 Gene Mutation; Ovarian Serous Adenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma
Interventions: Biological: Durvalumab; Other: Laboratory Biomarker Analysis; Drug: Olaparib; Biological: Tremelimumab
Sponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI)
Recruiting - Condition: Severe Asthma
Intervention:
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); University Medical Center Groningen
Recruiting - Conditions: Cirrhosis; Food Preferences; Taste Disorders; Protein-Energy Malnutrition; Chronic Renal Failure
Intervention:
Sponsor: University of Burgundy
Recruiting - Condition: Status Asthmaticus
Intervention: Drug: preservative free albuterol
Sponsor: Norton Healthcare
Not yet recruiting - Condition: Idiopathic Angioedema
Interventions: Drug: Omalizumab; Drug: Placebos
Sponsors: University of Wisconsin, Madison; Novartis Pharmaceuticals
Recruiting - Conditions: Aortitis; Cutaneous Vasculitis; Eosinophilic Granulomatosis With Polyangiitis; Giant Cell Arteritis; Granulomatosis With Polyangiitis (Wegener's); Henoch-Schonlein Purpura; IgA Vasculitis; Microscopic Polyangiitis; Polyarteritis Nodosa; Takayasu Arteritis; Churg-Strauss Syndrome
Intervention:
Sponsors: University of Pennsylvania; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Center for Advancing Translational Science (NCATS); Office of Rare Diseases (ORD)
Recruiting - Condition: Allergic Rhinitis
Interventions: Drug: EMS Mometasone gel; Drug: Mometasone spray nasal
Sponsor: EMS
Not yet recruiting - Condition: Asthma
Intervention: Device: Positive Expiratory Pressure
Sponsor: University of Vermont
Recruiting - Conditions: Moderate Persistent Asthma; Severe Persistent Asthma; Nodule Solitary Pulmonary; Pulmonary Atelectasis
Intervention: Procedure: Bronchial biopsy
Sponsor: Lu Yuan Lee
Not yet recruiting - Condition: Allergic Rhinitis
Interventions: Drug: EMS Mometasone gel; Drug: Mometasone spray nasal
Sponsor: EMS
Not yet recruiting - Condition: Asthma
Interventions: Drug: Dupilumab; Other: Placebo; Drug: Asthma Controller Therapies (incl. prednisone/prednisolone); Drug: Asthma Reliever Therapies
Sponsors: Sanofi; Regeneron Pharmaceuticals
Recruiting - Conditions: Obese; Metabolic Syndrome
Interventions: Drug: Mirabegron; Drug: Pioglitazone; Drug: Mirabegron and Pioglitazone
Sponsors: Philip Kern; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: Discoloured Teeth
Interventions: Device: Philips Zoom! White Speed whitening lamp; Device: Philips Zoom! Advanced power whitening lamp
Sponsors: Cairo University; British University In Egypt
Recruiting - Condition: Acute Urticaria
Interventions: Drug: Test Drug (JDP-205); Drug: Active Control (Diphenhydramine)
Sponsor: JDP Therapeutics, Inc.
Recruiting - Condition: Food Allergy
Interventions: Drug: Chinese Herbal Medication; Drug: Placebo; Drug: Omalizumab; Drug: Multi OIT
Sponsor: Xiu-Min Li
Recruiting - Condition: Apnea, Sleep
Intervention: Drug: Targeted infusion of remifentanil
Sponsor: Washington University School of Medicine
Recruiting - Condition: Macular Hole Surgery
Intervention:
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Recruiting - Conditions: Insulin Sensitivity; Glucose Tolerance; Sedentary Behaviour; Physical Activity
Interventions: Behavioral: Sit-stand desk; Behavioral: Sitting desk
Sponsor: University of Prince Edward Island
Recruiting - Condition: Pediatrics
Interventions: Behavioral: collection data; Behavioral: IRM
Sponsor: University Hospital, Strasbourg, France
Recruiting - Condition: Bronchial Asthma
Interventions: Drug: Ke Chuan Liu Wei Mixture; Drug: Chuan Xiong Ping Chuan Mixture; Drug: Xie Wu Capsule; Drug: Dan Ma Jia Tablet; Drug: Zhi Chuan Capsule; Drug: Bu Shen Na Qi Granule; Drug: Ke Chuan Liu Wei Mixture placebo; Drug: Chuan Xiong Ping Chuan Mixture placebo; Drug: Xie Wu Capsule placebo; Drug: Dan Ma Jia Tablet placebo; Drug: Zhi Chuan Capsule placebo; Drug: Bu Shen Na Qi Granule placebo
Sponsor: Shanghai University of Traditional Chinese Medicine
Not yet recruiting - Condition: Childhood Asthma With Status Asthmaticus
Intervention:
Sponsors: Erasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Radboud University; Maasstad Hospital; VU University Medical Center; UMC Utrecht; University Medical Center Groningen; Amphia Hospital; Rijnstate Hospital; Tergooi Hospital; Maastricht University Medical Center; Leiden University Medical Center
Recruiting - Condition: Rhinitis,Allergic
Interventions: Dietary Supplement: Broccoli Sprout Extract; Drug: fluticasone nasal; Dietary Supplement: brocooli sprout extract placebo; Drug: normal saline nasal spray
Sponsor: VA Office of Research and Development
Recruiting - Condition: Multiple Sclerosis
Intervention:
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Recruiting - Conditions: Primary Cutaneous Vasculitis; Cutaneous Polyarteritis Nodosa; IgA Vasculitis; Henoch-Schönlein Purpura
Interventions: Drug: Colchicine; Drug: Dapsone; Drug: Azathioprine
Sponsors: University of Pennsylvania; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Center for Advancing Translational Science (NCATS); Office of Rare Diseases (ORD)
Recruiting - Conditions: B Acute Lymphoblastic Leukemia; Central Nervous System Leukemia; Ph-Like Acute Lymphoblastic Leukemia; Testicular Leukemia; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: Clofarabine; Drug: Cyclophosphamide; Drug: Cytarabine; Drug: Dasatinib; Drug: Daunorubicin Hydrochloride; Drug: Dexamethasone; Drug: Doxorubicin Hydrochloride; Drug: Etoposide; Drug: Hydrocortisone Sodium Succinate; Other: Laboratory Biomarker Analysis; Drug: Leucovorin Calcium; Drug: Mercaptopurine; Drug: Methotrexate; Drug: Pegaspargase; Drug: Prednisone; Radiation: Radiation Therapy; Drug: Thioguanine; Drug: Vincristine Sulfate
Sponsor: National Cancer Institute (NCI)
Recruiting - Conditions: Obesity; Insulin Resistance; Sedentary Lifestyle
Interventions: Behavioral: Moderate intensity exercise training (MOD-INT); Behavioral: High Intensity exercise training (HI-INT)
Sponsor: East Carolina University
Recruiting - Condition: Prostate Cancer
Interventions: Radiation: Radiotherapy to the pelvis; Drug: Hormonal therapy (LHRH agonist and/or antiandrogens)
Sponsor: University Hospital "Sestre Milosrdnice"
Recruiting - Conditions: Atopic Dermatitis; Vascular Inflammation; Coronary Atherosclerosis
Interventions: Other: FDG-PET Scan; Other: MDCT; Other: biopsy and blood collection
Sponsors: Innovaderm Research Inc.; Montreal Heart Institute; Icahn School of Medicine at Mount Sinai
Recruiting - Conditions: Phobias; Claustrophobia; Social Phobia
Interventions: Behavioral: Extinction Training; Device: Low-Level Laser Therapy; Device: Sham Low-Level Laser Therapy
Sponsor: University of Texas at Austin
Recruiting - Conditions: Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms; Lung Diseases; Adenocarcinoma; Advanced Solid Tumors
Intervention: Drug: CK-101
Sponsor: Checkpoint Therapeutics, Inc.
Recruiting - Condition: Atopic Eczema
Intervention: Radiation: combined ultraviolet phototherapy (NB-UVB + UVA1) vs. NB-UVB monotherapy
Sponsors: University of Dundee; NHS Tayside
Recruiting - Condition: Asthma
Intervention: Behavioral: Electronic sensor and OW education
Sponsors: Montefiore Medical Center; Stony Wold-Herbert Fund, Inc.
Recruiting - Conditions: Invasive Cancer; Ductal Carcinoma in Situ
Interventions: Device: Ultrasonography; Device: Digital mammography
Sponsors: Soonchunhyang University Hospital; Ministry of Health & Welfare, Korea
Recruiting - Condition: Dermatitis, Atopic
Intervention: Drug: Nanodox 1% (doxycycline monohydrate hydrogel)
Sponsors: University of Florida; Alchem Laboratories, Inc
Recruiting - Condition: Neuropathic Pain
Interventions: Other: stimulation on painful area (area allodynic); Other: same stimulation on non-painful area; Radiation: MRI scan
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Recruiting - Condition: Dermatitis, Atopic
Intervention: Other: standardized skin care regimen
Sponsors: HiPP GmbH & Co. Vertrieb KG; Charite University, Berlin, Germany
Recruiting - Condition: Lung Neoplasms
Intervention:
Sponsors: Wissenschaftliches Institut Bethanien e.V; Merck Sharp & Dohme Corp.; Institute of Pathology, University Clinic Düsseldorf
Recruiting - Condition: Ovarian Cancer
Interventions: Drug: Olaparib; Drug: Cediranib; Drug: Platinum-based Chemotherapy
Sponsor: Rozalia Lubiatowska
Recruiting - Condition: Mild Asthma
Interventions: Drug: QMF149 150/80 μg; Drug: MF 200 μg
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Asthma
Interventions: Drug: Fluticasone furoate; Drug: Placebo; Drug: Montelukast; Drug: Short Acting Beta 2 Agonist
Sponsor: GlaxoSmithKline
Recruiting - Conditions: Asthma; Healthy
Intervention:
Sponsors: University of Michigan; National Institutes of Health (NIH)
Recruiting - Condition: Persistent Asthma
Intervention: Procedure: Bronchoscopy
Sponsors: University of Leicester; Genentech, Inc.; Queen's University, Belfast; Medical Research Council
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Other: Oral food desensitization
Sponsor: The University of Texas Health Science Center, Houston
Recruiting - Condition: Cystic Fibrosis
Intervention: Drug: Hyperpolarized Xenon
Sponsors: Children's Hospital Medical Center, Cincinnati; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Conditions: Asthmatic Crisis; Wheezing
Intervention: Dietary Supplement: Fultium-D3 drops (Internis)
Sponsor: Queen Mary University of London
Recruiting - Condition: First Manifestation of Steroid Sensitive Nephrotic Syndrome
Interventions: Drug: Levamisole Hydrochloride; Other: Placebo
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - Condition: Status Asthmaticus
Interventions: Drug: Ipratropium; Drug: 0.9% Sodium Chloride; Drug: Albuterol; Drug: corticosteroids
Sponsor: University Hospitals Cleveland Medical Center
Recruiting - Condition: Asthma
Intervention: Device: Targeted Lung Denervation (TLD)
Sponsor: Nuvaira, Inc.
Recruiting - Conditions: Exercised Induced Asthma; Asthma
Interventions: Dietary Supplement: HOST-DM059; Dietary Supplement: Maltodextrin
Sponsors: Nottingham Trent University; University of Reading; Clasado Biosciences; Imperial College London; HOST Therabiomics; The John van Geest Cancer Research Centre
Recruiting - Condition: Eosinophilic Esophagitis
Interventions: Drug: EMS Fluticasone 1; Drug: EMS Fluticasone 2; Drug: EMS Fluticasone 3; Other: EMS Placebo Fluticasone
Sponsor: EMS
Not yet recruiting - Condition: Bronchial Diseases
Interventions: Drug: ACT guided Routine Treatment; Drug: Routine Treatment
Sponsors: GlaxoSmithKline; Macrostat
Recruiting - Condition: Prostate Cancer Metastatic
Interventions: Drug: Enzalutamide; Procedure: 11C or 18F-Choline PET/CT; Procedure: Whole body MRI; Procedure: Bone scan
Sponsors: The European Uro-Oncology Group; Centre for Human Drug Research, Netherlands
Recruiting - Conditions: Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
Interventions: Drug: Chemotherapy; Drug: Rucaparib
Sponsors: Clovis Oncology, Inc.; Foundation Medicine
Recruiting - Conditions: Hereditary Angioedema; Healthy Volunteers
Intervention: Other: blood sample
Sponsor: University Hospital, Grenoble
Recruiting - Condition: Depressed
Intervention:
Sponsors: Dr. Kate Harkness; University Health Network, Toronto; University of Calgary; Harvard University; McGill University
Recruiting - Condition: Oral Immunotherapy for Food Allergy
Intervention:
Sponsor: Assaf-Harofeh Medical Center
Recruiting - Condition: Food Allergy
Intervention: Other: prick and patch test
Sponsor: Mahidol University
Recruiting - Conditions: Asthma; Allergic Rhinitis; Cystic Fibrosis; Pneumonia
Intervention:
Sponsor: Boston Children’s Hospital
Recruiting - Conditions: Chronic Obstructive Pulmonary Disease; Bronchial Asthma; Interstitial Lung Disease
Interventions: Device: multiple breath washout test (MBW); Device: impulse oscillometry (IOS); Device: body plethysmography (BP); Device: quantitative computed tomography (qCT)
Sponsor: Universitätsmedizin Mannheim
Recruiting - Condition: Bladder Cancer
Intervention:
Sponsor: University College, London
Recruiting - Condition: Asthma
Interventions: Behavioral: Lifestyle Factors; Other: Customized use of Dietary Supplements; Other: Currently Accepted Asthma Care Guidelines
Sponsor: The Cleveland Clinic
Recruiting - Conditions: Asthma; Major Depressive Disorder
Interventions: Drug: Escitalopram; Drug: Venlafaxine XR; Drug: Bupropion XR; Drug: Sertraline; Drug: Mirtazapine; Drug: Buspirone; Drug: Quetiapine; Drug: Aripiprazole; Drug: Lithium
Sponsors: University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute (NHLBI); University at Buffalo
Recruiting - Condition: Diabetes, Gestational
Intervention:
Sponsor: University of Aarhus
Recruiting - Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Bifidobacteria; Drug: placebo
Sponsor: University of Campania "Luigi Vanvitelli"
Recruiting - Conditions: Myelodysplastic Syndrome (MDS); Chronic Lymphocytic Leukemia (CLL); Chemotherapy-sensitive Lymphoma; Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma; Acute Myelogenous Leukemia (AML); Acute Biphenotypic Leukemia (ABL); Acute Undifferentiated Leukemia (AUL)
Interventions: Drug: Fludarabine; Drug: Cyclophosphamide 14.5 mg/kg/day IV on Days -6, -5; Radiation: Total Body Irradiation (TBI) 200cGy on Day -1; Procedure: Infusion of non-T-cell depleted bone marrow on Day 0; Drug: Busulfan; Drug: Cyclophosphamide 50mg/kg/day IV on Days -2,-1; Drug: Cyclophosphamide 50mg/kg/day IV on Days -5,-4; Radiation: Total Body Irradiation (TBI) 200cGy twice a day on Days -3, -2, -1; Drug: Post-HCT Cyclophosphamide 50mg/kg IV on Day+3, +4; Drug: Sirolimus; Drug: Mycophenolate mofetil; Drug: G-CSF; Drug: Pre-HCT Mesna on Days -6 and -5; Drug: Pre-HCT Mesna on Days -2 and -1; Drug: Pre-HCT Mesna on Days -5 and -4; Drug: Post-HCT Mesna
Sponsors: Center for International Blood and Marrow Transplant Research; National Marrow Donor Program; Resource for Clinical Investigation in Blood and Marrow Transplantation
Recruiting - Conditions: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia
Interventions: Drug: Cyclophosphamide; Drug: Cytarabine; Drug: Dasatinib; Drug: Dexamethasone; Drug: Doxorubicin Hydrochloride; Drug: Idarubicin; Drug: Idelalisib; Device: In Vitro Kinase Inhibitor Assay; Drug: Leucovorin Calcium; Drug: Methotrexate; Drug: Methylprednisolone Sodium Succinate; Drug: Ponatinib Hydrochloride; Biological: Rituximab; Drug: Ruxolitinib Phosphate; Drug: Sorafenib Tosylate; Drug: Sunitinib Malate; Drug: Vincristine Sulfate
Sponsors: OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - Condition: Insulin Sensitivity/Resistance
Intervention: Other: 8 weeks of combined exercise intervention
Sponsor: University of Texas, El Paso
Recruiting - Condition: Stroke
Intervention: Other: Non-Interventional
Sponsors: Valtari Bio; University of Cincinnati; University of Texas at Austin
Recruiting - Conditions: Asthma; Wheeze; Obstructive Sleep Apnea; Food Allergy; Virus
Interventions: Procedure: Bronchodilator response; Procedure: Allergy Skin Test; Procedure: Multiple-Breath Washout; Procedure: Forced Oscillation Technique; Procedure: Spirometry; Drug: salbutamol; Procedure: Nasal Brush; Procedure: Blood sample; Procedure: Basophil activation test; Procedure: Nasal swab
Sponsors: The Hospital for Sick Children; Dalhousie University
Recruiting - Condition: Asthma
Intervention: Other: Not an interventional study
Sponsor: Boston Children’s Hospital
Recruiting - Condition: Metastatic Renal Cell Carcinoma
Intervention:
Sponsors: Pfizer; TFS Trial Form Support
Recruiting - Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs); Eosinophilic Esophagitis (EoE)
Interventions: Other: elimination diet therapy; Drug: Flovent
Sponsors: Children's Hospital Medical Center, Cincinnati; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); Office of Rare Diseases (ORD); National Center for Advancing Translational Science (NCATS)
Recruiting - Condition: Asthma
Intervention:
Sponsor: University of Texas Southwestern Medical Center
Recruiting - Conditions: Lung Transplant; Lung Resection; Lung Cancer; Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Emphysema; Mesothelioma; Asbestosis; Pulmonary Embolism; Interstitial Lung Disease; Pulmonary Fibrosis; Bronchiectasis; Seasonal Allergies; Cold Virus; Lung Infection; Pulmonary Hypertension; Pulmonary Dysplasia; Obstructive Sleep Apnea
Interventions: Drug: HP 3He; Drug: HP 129Xe; Drug: PFP; Drug: SF6; Device: 129Xe Small and Large Human Lung Coil; Device: 3He Human Lung Coil; Device: PFP and SF6 Human Lung Coil
Sponsors: Thunder Bay Regional Research Institute; Thunder Bay Regional Health Sciences Centre; St. Joseph's Care Group; Lakehead University
Not yet recruiting - Condition: Eosinophilic Esophagitis
Intervention: Other: Observation Period
Sponsors: University of Wisconsin, Madison; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Gestational Diabetes Mellitus
Intervention: Other: Oral glucose tolerance test
Sponsor: Massachusetts General Hospital
Recruiting - Conditions: Asthma; COPD; Chronic Obstructive Pulmonary Disease
Interventions: Procedure: Blood draw; Procedure: Urine; Procedure: Lung function measurements; Procedure: Fractional Exhaled Nitric Oxide (FENO)
Sponsors: AstraZeneca; Parexel
Recruiting - Condition: Asthma
Interventions: Device: Active Air Purifier; Device: Placebo Air Purifier
Sponsor: Johns Hopkins University
Recruiting - Condition: Asthma
Interventions: Genetic: Personalised medicine (Salmeterol); Genetic: Personalised medicine (Montelukast); Other: Standard care
Sponsor: University of Sussex
Recruiting - Conditions: Urticaria Pigmentosa; Cutaneous Mastocytosis
Interventions: Other: skin biopsy; Other: blood draw
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - Conditions: Cardiac Arrest; Acute Coronary Lesion; Stable Obstructive Coronary Disease; Non-obstructive Coronary Disease
Intervention: Other: Blood sample collection
Sponsor: University Medical Centre Ljubljana
Recruiting - Condition: Asthma
Interventions: Other: TEAM-ED; Other: Enhanced Usual Care
Sponsor: University of Rochester
Recruiting - Conditions: Asthma; OSA
Intervention: Device: continuous positive airway pressure (CPAP)
Sponsors: Chang Gung Memorial Hospital; Ministry of Science and Technology, Taiwan
Recruiting - Conditions: Ovarian Cancer; Peritoneal Carcinomatosis; Fallopian Tube Cancer
Intervention: Biological: GL-ONC1
Sponsor: Genelux Corporation
Recruiting - Conditions: Posttraumatic Stress Disorder; Stress; Anxiety; Depression
Intervention: Behavioral: joint observation and video feedback
Sponsor: Centre Hospitalier Universitaire Vaudois
Recruiting - Condition: Allergies
Interventions: Other: Phthalate; Other: Filtered Air; Other: Allergen
Sponsor: University of British Columbia
Recruiting - Condition: Asthma
Interventions: Drug: Fluticasone propionate HFA 220; Drug: Placebo
Sponsor: New York University School of Medicine
Recruiting - Condition: Impaired Glucose Tolerance
Interventions: Drug: Gymnema Sylvestre; Drug: Placebo
Sponsor: University of Guadalajara
Recruiting - Condition: Insulin Sensitivity
Interventions: Dietary Supplement: carnosine; Other: Placebo
Sponsor: Monash University
Recruiting - Condition: Eosinophilic Esophagitis (EoE)
Interventions: Drug: Oral Budesonide Suspension (OBS); Drug: Placebo
Sponsor: Shire
Recruiting - Conditions: Cancer Prevention; Tobacco Use Cessation
Interventions: Behavioral: Questionnaires; Behavioral: CO Level Testing; Behavioral: Behavior Activation Treatment (BAT); Behavioral: Standard Cessation (SC); Drug: Nicotine Patch; Behavioral: Cotinine Level Testing; Procedure: Lab Session
Sponsors: M.D. Anderson Cancer Center; National Institute on Drug Abuse (NIDA)
Recruiting - Conditions: Pediatric Obesity; Obesity
Interventions: Behavioral: Healthy Caregivers- Healthy Children Toolkit; Behavioral: Safety Curriculum
Sponsor: University of Miami
Recruiting - Conditions: Colorectal Neoplasms; Colorectal Cancer; Breast Cancer; Breast Neoplasms; Ovarian Cancer; Ovarian Neoplasm
Intervention: Other: Molecular Profiling & In Vivo drug testing in pPDX and organoid cultures
Sponsor: University Health Network, Toronto
Recruiting - Condition: Headache Migraine Chronic
Interventions: Device: Gray tinted spectacle lenses; Device: Thin-Film spectacle lenses
Sponsors: University of Utah; Axon Optics, LLC; Mayo Clinic; Brigham and Women's Hospital; Northwell Health
Recruiting - Conditions: Asthma; Childhood Asthma
Interventions: Behavioral: PEF Feedback; Behavioral: Control Feedback
Sponsors: Albert Einstein College of Medicine, Inc.; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Allergic Rhinitis
Interventions: Biological: ILIT with extract of causal allergen; Biological: ILIT with normal saline; Drug: Rescue medication for allergic rhinitis
Sponsors: Gachon University Gil Medical Center; Korea Research Foundation
Recruiting - Conditions: Rhinitis; Rhinoconjunctivitis
Interventions: Biological: MM09 Mannosylated 5.000 subcutaneous; Biological: MM09 Mannosylated 10.000 subcutaneous; Biological: MM09 Mannosylated 30.000 subcutaneous; Biological: MM09 Mannosylated 50.000 subcutaneous; Biological: MM09 Mannosylated 5.000 sublingual; Biological: MM09 Mannosylated 10.000 sublingual; Biological: MM09 Mannosylated 30.000 sublingual; Biological: MM09 Mannosylated 50.000 sublingual; Biological: Subcutaneous placebo; Biological: Sublingual placebo
Sponsor: Inmunotek S.L.
Recruiting - Conditions: Rhinitis; Rhinoconjunctivitis
Interventions: Biological: MG56 Mannosylated 60 subcutaneous; Biological: MG56 Mannosylated 100 subcutaneous; Biological: MG56 Mannosylated 300 subcutaneous; Biological: MG56 Mannosylated 500 subcutaneous; Biological: MG56 Mannosylated 60 sublingual; Biological: MG56 Mannosylated 100 sublingual; Biological: MG56 Mannosylated 300 sublingual; Biological: MG56 Mannosylated 500 sublingual; Biological: Subcutaneous placebo; Biological: Sublingual placebo
Sponsor: Inmunotek S.L.
Recruiting - Condition: Asthma
Intervention: Device: Positive Expiratory Pressure
Sponsor: University of Vermont
Recruiting - Condition: Myocardial Infarction
Intervention: Procedure: Accelerated, combined biomarker rule-out strategy for MI
Sponsor: Aarhus University Hospital Skejby
Recruiting - Condition: Asthma
Interventions: Drug: vitamin D3 4000 IU; Drug: Placebo
Sponsors: Juan Celedon, MD; Pharmavite; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Conditions: Prostate Cancer; Prostate Neoplasms; Neoplasms, Prostatic
Interventions: Biological: PROSTVAC-V; Biological: PROSTVAC-F; Drug: Docetaxel
Sponsor: National Cancer Institute (NCI)
Recruiting - Conditions: Pre-diabetes; Metabolic Syndrome
Interventions: Dietary Supplement: Active; Dietary Supplement: Control
Sponsor: Institute for Food Safety and Health, United States
Recruiting - Condition: Stress Disorders, Post-traumatic
Interventions: Behavioral: Trauma Sensitive Yoga Intervention; Behavioral: Cognitive Processing Therapy-Cognitive Only
Sponsor: VA Office of Research and Development
Recruiting - Condition: Adolescent Substance Use
Interventions: Behavioral: Teen Intervene; Behavioral: Everyday Parenting
Sponsors: University of Minnesota - Clinical and Translational Science Institute; National Institute on Drug Abuse (NIDA); Natalis Counseling Center
Recruiting - Conditions: Adverse Reaction to Drug; Allergic Reaction to Contrast Media
Intervention: Drug: Gadoteric Acid
Sponsor: St. Louis University
Recruiting - Condition: Metastatic Breast Cancer
Interventions: Drug: Vinorelbine; Drug: DDP
Sponsor: Fudan University
Recruiting - Condition: Hypersensitivity
Interventions: Drug: Mometasone furoate drug formulation (MFF) 1; Drug: Mometasone furoate drug formulation (MFF) 2
Sponsors: University of Florida; Food and Drug Administration (FDA)
Not yet recruiting - Conditions: Asthma; Allergic Rhinitis
Intervention: Other: Lung Function Assessment
Sponsor: Stefania La Grutta, MD
Recruiting - Condition: Dermatitis, Atopic
Interventions: Other: Individual session therapeutic education; Other: Phone Call
Sponsor: Nantes University Hospital
Recruiting - Condition: Asthma
Interventions: Drug: Mannitol; Drug: Methacholine; Drug: Placebo; Other: Rest; Other: Exercise
Sponsor: University of Alberta
Recruiting - Condition: Nasopharyngeal Cancinoma (NPC)
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - Condition: Ovarian Carcinoma
Interventions: Drug: Tamoxifen; Drug: Regorafenib
Sponsors: ARCAGY/ GINECO GROUP; Bayer
Recruiting - Conditions: Asthma; Hyperinflation
Intervention: Procedure: Bronchial thermoplasty for treatment of severe asthma
Sponsor: University Hospital, Toulouse
Recruiting - Condition: Colon Adenocarcinoma
Interventions: Drug: Carbon C 14 Oxaliplatin; Drug: Oxaliplatin
Sponsors: University of California, Davis; National Cancer Institute (NCI)
Recruiting - Condition: Eclampsia
Intervention:
Sponsor: Medical University of Graz
Recruiting - Condition: Eosinophilic Esophagitis (EoE)
Interventions: Drug: Oral Budesonide Suspension (OBS); Drug: Placebo
Sponsor: Shire
Recruiting - Condition: Eosinophilic Esophagitis
Interventions: Device: Cytosponge; Other: Diet; Other: Phone call; Other: EEsAI Pro
Sponsor: Mayo Clinic
Recruiting - Condition: Irritable Bowel Syndrome
Intervention: Procedure: Colonoscopy with eleven biopsies in the left colon to assess intestinal permeability
Sponsors: University Hospital, Rouen; Société Nationale Française de Gastroentérologie
Recruiting - Conditions: Vasculitis; Behcet's Disease; CNS Vasculitis; Cryoglobulinemic Vasculitis; Eosinophilic Granulomatosis With Polyangiitis (EGPA); Churg-Strauss Syndrome (CSS); Granulomatosis With Polyangiitis (GPA); Wegener's Granulomatosis; IgA Vasculitis; Henoch-Schoenlein Purpura (HSP); Microscopic Polyangiitis (MPA); Polyarteritis Nodosa (PAN); Takayasu Arteritis (TAK); Urticarial Vasculitis; Systemic Vasculitis
Intervention: Other: Online questionnaires
Sponsors: University of Pennsylvania; Duke University; University of South Florida
Recruiting - Conditions: Patch,Chinese Herb; Moxibustion; Allergic Rhinitis
Interventions: Drug: Sanfu herbal patch; Drug: Sanfu moxibustion; Drug: Sanfu herbal patch and moxibustion
Sponsor: Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust
Recruiting - Conditions: Vocal Cord Tension; Dysfluency Developmental
Intervention: Other: Food Allergy Testing and Elimination Diet
Sponsor: The R2 Institute
Not yet recruiting - Conditions: Acute Leukemia of Ambiguous Lineage; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Refractory Childhood Acute Lymphoblastic Leukemia
Interventions: Other: Chemosensitivity Assay; Other: Cytology Specimen Collection Procedure; Genetic: Gene Expression Analysis; Genetic: Genetic Variation Analysis; Drug: In Vitro Sensitivity-Directed Chemotherapy
Sponsors: University of Washington; National Cancer Institute (NCI)
Recruiting - Conditions: Adverse Drug Event; Adverse Drug Reaction; Chinese Medicine; Anaphylactic Reaction
Intervention: Drug: Breviscapine Powder-Injection
Sponsor: Zhong Wang
Recruiting - Condition: Asthma
Interventions: Drug: Omalizumab; Drug: Placebo
Sponsor: Wanda Phipatanakul
Not yet recruiting - Condition: Asthma
Interventions: Drug: QVM149; Drug: QMF149; Drug: salmeterol/fluticasone
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Asthma
Intervention: Other: 1 year Observational Follow-up
Sponsor: University of Pittsburgh
Recruiting - Condition: Breast Cancer
Interventions: Device: KIBUR MICRODEVICE; Drug: anthracycline and taxane based chemotherapy
Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting - Condition: Asthma
Interventions: Drug: QAW039; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Severe Eosinophilic Asthma
Interventions: Drug: OC000459; Drug: Placebo
Sponsor: Atopix Therapeutics, Ltd.
Recruiting - Condition: Asthma
Interventions: Drug: QAW039; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Asthma
Interventions: Biological: Mepolizumab 100mg; Drug: Placebo
Sponsor: GlaxoSmithKline
Recruiting - Conditions: Very Long-chain Acyl-CoA Dehydrogenase Deficiency; Trifunctional Protein Deficiency; Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency; Medium-chain Acyl-CoA Dehydrogenase Deficiency; Normal Volunteers; Carnitine Palmitoyltransferase II Deficiency, Myopathic
Interventions: Drug: Intralipid/Heparin; Drug: Glycerol/Saline; Drug: Hyperinsulinemic euglycemic clamp
Sponsor: Oregon Health and Science University
Recruiting - Conditions: Food Allergy; Loeys-Dietz Syndrome
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Asthma
Interventions: Drug: QMF149; Drug: MF 400; Drug: salmeterol /fluticasone
Sponsor: Novartis Pharmaceuticals
Recruiting - Conditions: Hypersensitivity, Immediate; Insect Bites and Stings; Mastocytosis
Intervention:
Sponsor: Meir Medical Center
Recruiting - Conditions: Allergy to Fish; Allergy to Shrimp; Allergy to Crab
Interventions: Dietary Supplement: Treatment - Chinese Herbal Formula - X; Dietary Supplement: Placebo
Sponsors: Hong Kong Sanatorium & Hospital; Chinese University of Hong Kong
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Cholecalciferol; Drug: Placebo of cholecalciferol
Sponsor: Rennes University Hospital
Recruiting - Condition: Henoch-Schoenlein Purpura
Interventions: Drug: Dexamethasone; Drug: Gamma globulin; Procedure: Hemoperfusion
Sponsor: Nanjing Children's Hospital
Recruiting - Conditions: Asthma; Wheeze; Hypersensitivity; Endophenotype
Intervention:
Sponsors: Klinikum der Universitaet Muenchen; German Federal Ministry of Education and Research; German Center for Lung Research; Comprehensive Pulmonary Center Munich; Airway Research Center North; Biomedical Research in Endstage and Obstructive Lung Disease Hannover; Translational Lung Research Center Heidelberg; Universities of Giessen and Marburg Lung Center
Recruiting - Condition: Egg Hypersensitivity
Intervention: Behavioral: shorter or longer period of specific dietary restrictions
Sponsors: Dominque Bullens; Jessa Hospital; Algemeen Ziekenhuis Maria Middelares; Imelda Hospital, Bonheiden; AZ Sint-Jan AV
Recruiting - Condition: Gastric and Cardia Adenocarcinomas
Intervention: Procedure: Biopsy
Sponsor: University Hospital, Strasbourg, France
Recruiting - Condition: Henoch-Schoenlein Purpura Nephritis
Interventions: Drug: Prednisone; Drug: ACEI
Sponsor: Nanjing Children's Hospital
Recruiting - Condition: Henoch-Schoenlein Purpura Nephritis
Interventions: Drug: Prednisone; Drug: Cyclophosphamide(CTX); Drug: Mycophenolate mofetil(MMF); Drug: Leflunomide(LEF); Drug: Angiotensin-converting enzyme inhibitor(ACEI); Drug: Methylprednisolone
Sponsor: Nanjing Children's Hospital
Recruiting - Conditions: Hypotension; Postoperative Complications; Acute Coronary Syndrome; Heart Failure; Coronary Occlusion; Stroke; Acute Kidney Injury; Renal Insufficiency, Chronic; Death
Interventions: Drug: Liberal blood pressure management; Drug: Tight blood pressure management
Sponsor: Miodrag Filipovic, Prof. Dr. med.
Recruiting - Condition: Dermatitis, Allergic Contact
Intervention: Other: Patch Test
Sponsors: Winthrop University Hospital; Smart Practice
Recruiting - Condition: Asthma
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Inner-City Asthma Consortium
Recruiting - Condition: BRCA or HRR+ Mutated Ovarian Cancer Patients
Intervention: Drug: Olaparib
Sponsor: AstraZeneca
Recruiting - Condition: Neoplasm
Intervention: Drug: Crizotinib
Sponsor: Pfizer
Available - Condition: Cough
Intervention: Other: Citric Acid
Sponsors: Mayo Clinic; University of Manchester
Recruiting - Condition: Healthy
Intervention: Device: Polarization-Sensitive OFDI
Sponsors: Massachusetts General Hospital; Massachusetts Eye and Ear Infirmary
Not yet recruiting - Conditions: Aortic Stenosis; Heart Failure; Syncope; Angina Pectoris
Intervention: Procedure: Aortic Valve Intervention (surgical or transcatheter)
Sponsor: Medical University Innsbruck
Recruiting - Condition: Non-celiac Wheat Sensitivity
Intervention:
Sponsor: University of Palermo
Recruiting - Condition: Non-Celiac Wheat Sensitivity
Intervention:
Sponsor: University of Palermo
Recruiting - Condition: Non-celiac Wheat Sensitivity
Intervention:
Sponsor: University of Palermo
Recruiting - Condition: Asthma
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Conditions: Peanut Hypersensitivity; Anaphylaxis
Interventions: Other: Questionnaire; Other: Peanut Skin prick test; Other: Fraction of exhaled nitric oxide; Other: Spirometry; Other: Serum Peanut and Ara h2 specific immunoglobulin E; Other: Collection of blood biomarker; Other: Peanut food challenge
Sponsors: John Hunter Children's Hospital; Hunter Medical Research Institute, Australia; University of Newcastle, Australia; Thrasher Research Fund; Hunter Childrens Research Foundation, Australia; Aerocrine AB
Recruiting - Condition: Asthma
Interventions: Device: AccuPAP; Drug: Albuterol and Ipratropium Continuous Nebulizer
Sponsor: Vanderbilt University Medical Center
Recruiting - Condition: Bronchial Asthma
Interventions: Drug: Intravenous magnesium sulfate; Drug: Inhaled budesonide; Drug: normal saline
Sponsor: Hamad Medical Corporation
Recruiting - Condition: Eosinophilic Esophagitis
Intervention:
Sponsor: University of Colorado, Denver
Recruiting - Condition: Allergic Bronchopulmonary Aspergillosis
Interventions: Drug: Itraconazole; Drug: Glucocorticoids
Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting - Condition: Asthma
Interventions: Behavioral: Targeted text messages; Behavioral: General text messages
Sponsors: Children's Hospitals and Clinics of Minnesota; HealthPartners Institute
Recruiting - Condition: Asthma
Intervention:
Sponsor: Stefania La Grutta, MD
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Other: Antigen (wheat base soy sauce) spray
Sponsor: Mayo Clinic
Recruiting - Conditions: Hypertension; Stress, Psychological; Blood Pressure
Interventions: Drug: Prazosin; Drug: Placebo
Sponsors: Augusta University; The University of Texas at Arlington
Recruiting - Condition: Asthma
Intervention:
Sponsors: LungenClinic Grosshansdorf; German Center for Lung Research; Research Center Borstel
Recruiting - Condition: Lung Neoplasms
Intervention: Other: ALK analysis on CTCs detected by ISET
Sponsor: Centre Hospitalier Universitaire de Nice
Recruiting - Conditions: Hypertension; Obesity; Stress, Psychological; Blood Pressure
Interventions: Drug: Irbesartan; Other: Placebo
Sponsor: Augusta University
Recruiting - Conditions: Irritable Bowel Syndrome; Visceral Hypersensitivity
Interventions: Procedure: Gastrointestinal Permeability Test; Procedure: Upper Endoscopy; Procedure: Rectal Barostat and Infusion of Fats
Sponsors: Mayo Clinic; University of Erlangen-Nürnberg; Heidelberg University; University of Leeds
Recruiting - Conditions: Obesity; Insulin Resistance
Interventions: Procedure: Fat biopsy during scheduled abdominal surgery; Procedure: Fat Aspiration; Dietary Supplement: Fish Oil Supplement
Sponsor: Mayo Clinic
Recruiting - Condition: Asthma
Intervention: Biological: Segmental Bronchoprovocation with Allergen (SBP-Ag)
Sponsors: Lu Yuan Lee; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Conditions: Obesity; Insulin Resistance; Insulin Sensitivity; Beta-Cell Dysfunction; Prediabetes
Interventions: Dietary Supplement: Placebo; Dietary Supplement: Low-Dose Vitamin K2 Supplement (menaquinone-7; 90-mcg/d); Dietary Supplement: High-Dose Vitamin K2 Supplement (menaquinone-7; 180-mcg/d)
Sponsors: Augusta University; University of Alabama at Birmingham; Yale University; Tufts University; Nattopharma ASA
Recruiting - Condition: Advanced Stage Non-small Cell Lung Cancer
Interventions: Drug: nivolumab; Drug: pilimumab
Sponsors: Memorial Sloan Kettering Cancer Center; Bristol-Myers Squibb
Recruiting - Conditions: Impairment of Oral Perception; Insulin Resistance
Interventions: Dietary Supplement: Sucralose; Dietary Supplement: Sucrose; Dietary Supplement: Sucralose + maltodextrin; Dietary Supplement: Sucralose + Sucrose
Sponsor: Yale University
Recruiting - Conditions: Esophageal Stricture; Eosinophilic Esophagitis; Zenkers Diverticulum; Schatzki Ring
Intervention: Device: EndoFLIP
Sponsor: University of Pennsylvania
Recruiting - Conditions: Cat Allergy; Cat Hypersensitivity
Interventions: Drug: Cat-PAD; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Circassia Limited
Recruiting - Condition: Colorectal Cancer
Intervention: Procedure: Flexible sigmoidoscopy or colonoscopy
Sponsors: Dr. Frank ter Borg MD PhD; Erasmus Medical Center; The Netherlands Cancer Institute; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); UMC Utrecht
Recruiting - Condition: Non Coeliac Gluten Sensitivity
Interventions: Other: Normal gluten containing bread; Other: Bread with reduced gliadins content; Other: Bread with reduced ATIs content; Other: Bread with reduced overall protein content
Sponsor: University of Aberdeen
Recruiting - Condition: Asthma
Intervention: Other: Hyperpolarized Noble Gas MRI
Sponsor: Dr. Grace Parraga
Recruiting - Conditions: Acute Coronary Syndrome; Myocardial Infarction; Chest Pain
Intervention:
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Recruiting - Condition: Platinum-Sensitive Ovarian Cancer in First Relapse
Interventions: Drug: Farletuzumab; Drug: Placebo
Sponsors: Morphotek; Eisai Co., Ltd.
Recruiting - Condition: Asthma
Intervention:
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Recruiting - Conditions: Atopic Dermatitis; Food Allergies
Interventions: Drug: B. infantis; Drug: Placebo
Sponsor: Emanual Maverakis, MD
Recruiting - Condition: Chronic Rhinosinusitis
Interventions: Drug: Itraconazole; Drug: Placebo
Sponsor: The University of Texas Health Science Center, Houston
Recruiting - Condition: Toxic Epidermal Necrolysis
Interventions: Drug: Clobetasol 0.05% ointment; Drug: Placebo
Sponsor: University of California, Davis
Recruiting - Conditions: Adenocarcinoma of the Prostate; Recurrent Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer
Interventions: Drug: Enzalutamide; Drug: leuprolide acetate; Drug: goserelin acetate; Drug: histrelin acetate; Drug: triptorelin; Drug: degarelix
Sponsor: University of Colorado, Denver
Recruiting - Condition: Henoch Schönlein Purpura
Interventions: Biological: Blood samples; Biological: Stool samples
Sponsor: Centre Hospitalier Universitaire de Nīmes
Recruiting - Condition: Colon Cancer
Intervention: Drug: Omalizumab
Sponsor: Yale University
Recruiting - Condition: Sleep Apnea
Intervention:
Sponsor: University of Texas Southwestern Medical Center
Recruiting - Condition: Asthma
Interventions: Behavioral: AIM2ACT; Behavioral: Self-guided
Sponsors: University of Florida; The Miriam Hospital; Rhode Island Hospital; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Condition: Asthma
Interventions: Other: integrated pest management; Other: air purifier; Other: No intervention (control)
Sponsors: Boston Children’s Hospital; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Asthma
Interventions: Behavioral: Mindfulness Based Stress Reduction (MBSR); Behavioral: Healthy Living Course (HLC)
Sponsors: University of Massachusetts, Worcester; The Miriam Hospital; National Center for Complementary and Integrative Health (NCCIH)
Recruiting - Conditions: Atopic Dermatitis; Acne Rosacea; Acne Vulgaris
Intervention:
Sponsor: Innovaderm Research Inc.
Recruiting - Condition: Cutaneous Nerves CNS Itch
Interventions: Drug: Clonidine; Drug: Naltrexone
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - Condition: Food Allergy
Interventions: Other: SLIT to cow's milk; Other: Low dose OIT; Other: Conventional OIT to cow's milk
Sponsors: Imperial College London; JP Moulton Charity Foundation; Sociedad Española de Alergología e Inmunología; Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica
Recruiting - Conditions: Stroke; Brain Infarction; Brain Ischemia; Cerebral Infarction; Cerebrovascular Disorders
Interventions: Behavioral: Early Intensive upper extremity motor training; Behavioral: Sub-acute intensive upper extremity motor training; Behavioral: Chronic intensive upper extremity motor training; Behavioral: Control
Sponsors: MedStar National Rehabilitation Network; Georgetown University; University of Wisconsin, Madison; The Catholic University of America; Medstar Health Research Institute
Recruiting - Condition: Asthma
Interventions: Other: NO2 Scrubber; Other: HEPA filter; Other: Control
Sponsors: Yale University; Harvard University; National Institute of Environmental Health Sciences (NIEHS)
Recruiting - Condition: Asthma
Interventions: Drug: Flovent Diskus; Other: Home Environmental Intervention; Drug: Advair Diskus
Sponsor: Johns Hopkins University
Recruiting - Condition: Not-celiac Gluten Sensitivity
Intervention:
Sponsor: University of Palermo
Recruiting - Conditions: Peanut Allergies; Tree Nut Allergies; Other Food Allergies
Intervention:
Sponsors: University of Colorado, Denver; National Institutes of Health (NIH)
Recruiting - Condition: Peanut Allergy
Intervention:
Sponsor: Weill Medical College of Cornell University
Recruiting - Condition: Rejection Sensitivity
Intervention:
Sponsors: Stony Brook University; University of Michigan; National Institute of Mental Health (NIMH)
Recruiting - Conditions: Pompe Disease; Hypersensitivity Reaction
Intervention: Drug: Zavesca® Prescription
Sponsors: University of Florida; Amicus Therapeutics
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Device: SECM Capsule
Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: Signs and Symptoms
Intervention: Device: Acoustic Angiography
Sponsors: UNC Lineberger Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - Condition: Asthma
Interventions: Behavioral: School-Based Asthma Care for Teens (SB-ACT); Behavioral: Directly Observed Therapy; Behavioral: Asthma Education
Sponsors: University of Rochester; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Conditions: Barrett's Esophagus; Eosinophilic Esophagitis
Intervention: Device: OFDI Capsule
Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting - Condition: Hypersensitivity
Interventions: Device: Sensodyne; Device: Crest Cavity Protection & MI Paste Plus; Device: Clinpro 5000
Sponsor: Tufts University School of Dental Medicine
Recruiting - Condition: Asthma
Interventions: Other: Interactive SMS; Other: Usual care
Sponsors: University of British Columbia; WelTel; College of Pharmacists of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting - Conditions: Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative; Philadelphia Chromosome Positive; Recurrent Adult Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Lymphoblastic Leukemia
Interventions: Biological: Blinatumomab; Drug: Dasatinib; Other: Laboratory Biomarker Analysis; Drug: Mercaptopurine; Drug: Methotrexate; Drug: Prednisone; Drug: Vincristine Sulfate
Sponsor: National Cancer Institute (NCI)
Recruiting - Condition: Insulin Sensitivity
Interventions: Drug: Maltodextrin; Drug: Synbiotic; Drug: Sevelamer
Sponsors: The University of Texas Health Science Center at San Antonio; American Diabetes Association
Recruiting - Condition: Food Allergy
Interventions: Drug: Vitamin D; Drug: placebo
Sponsor: Murdoch Childrens Research Institute
Recruiting - Condition: Insulin Sensitivity
Interventions: Drug: Sevelamer; Drug: Synbiotic; Drug: Maltodextrin
Sponsors: The University of Texas Health Science Center at San Antonio; American Diabetes Association
Recruiting - Condition: Allergic Rhinoconjunctivitis
Intervention: Biological: Immunotherapy
Sponsor: Medical University of Graz
Recruiting - Condition: Cow Milk Allergy
Intervention:
Sponsor: Federico II University
Recruiting - Condition: Hypertension
Interventions: Drug: DEFINITY® infusion; Drug: Human Recombinant Regular Insulin infusion; Drug: Dextrose infusion; Procedure: Flow mediated vasodilation; Procedure: Endothelial cell collection; Procedure: Microvascular perfusion assessment using Definity; Procedure: Microneurography
Sponsor: University of Texas Southwestern Medical Center
Recruiting - Condition: Low Dose Methotrexate in Severe Chronic Asthma
Interventions: Drug: Methotrexate; Drug: Placebo
Sponsor: Universita degli Studi di Catania
Not yet recruiting - Condition: Asthma
Intervention:
Sponsor: University of California, San Francisco
Recruiting - Conditions: Skipping Breakfast; Circadian Rhythms
Interventions: Other: 3 standard meals/day; Other: 2 meals/day (omit breakfast)
Sponsor: Washington University School of Medicine
Recruiting - Conditions: Celiac Disease; Eosinophilic Esophagitis
Intervention:
Sponsors: Tampere University Hospital; Carol Davila University of Medicine and Pharmacy
Recruiting - Conditions: Lung Diseases; Medication Compliance
Interventions: Drug: Fluticasone propionate 230mcg for 3 Months; Drug: Current Treatment or no treatment; Drug: Salmeterol 21mcg for 3 Months
Sponsors: New York University School of Medicine; National Institute for Occupational Safety and Health (NIOSH/CDC)
Recruiting - Conditions: Allergy to Egg; Allergy to Peanut
Intervention: Biological: Basophil Activation Test
Sponsor: University Hospital, Rouen
Recruiting - Condition: Obesity
Intervention: Other: Exercise
Sponsors: University of Michigan; American Diabetes Association
Recruiting - Condition: Eosinophilic Esophagitis
Intervention:
Sponsors: University of Colorado, Denver; University of Illinois at Chicago; Northwestern University; OSF St. Francis Medical Center
Recruiting - Conditions: Obesity; Insulin Resistance; Insulin Sensitivity; Prediabetes; Dyslipidemia; Diabetes
Interventions: Dietary Supplement: Placebo-Control; Dietary Supplement: Low-Dose Vitamin K2 (menaquinone-7; 45 mcg/d); Dietary Supplement: High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)
Sponsors: Augusta University; University of Alabama at Birmingham; Yale University; Tufts University; Nattopharma ASA
Recruiting - Conditions: Diarrhea; Atopic Dermatitis
Intervention: Dietary Supplement: Probiotic
Sponsor: Nestlé
Recruiting - Conditions: Small Cell Lung Carcinoma; Non Small Cell Lung Carcinoma; Irinotecan Sensitive Cancers
Interventions: Drug: Carfilzomib; Drug: Irinotecan
Sponsors: Cancer Research and Biostatistics Clinical Trials Consortium; Lucille P. Markey Cancer Center at University of Kentucky; Washington University School of Medicine
Recruiting - Conditions: Middle Ear Disease; Nasal Allergy
Interventions: Biological: ragweed; Biological: histamine; Drug: pseudoephedrine; Drug: Oxymetazoline
Sponsors: Cuneyt M. Alper; National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - Condition: Tuberculosis
Interventions: Drug: Isoniazid; Dietary Supplement: Vitamin B6
Sponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Device: Mucosal Impedance
Sponsor: Mayo Clinic
Recruiting - Condition: Pain
Intervention: Drug: Duloxetine
Sponsors: University of Utah; American Cancer Society, Inc.
Recruiting - Conditions: Celiac Disease; Celiac Sprue; Gluten Enteropathy; Gluten-Sensitive Enteropathy
Intervention: Biological: Hu-Mik- Beta-1
Sponsors: National Cancer Institute (NCI); Mayo Clinic
Recruiting - Condition: Asthma
Intervention:
Sponsors: University of Wisconsin, Madison; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Conditions: Food Allergy; Eosinophilic Esophagitis
Intervention:
Sponsors: Children's Hospital of Philadelphia; University of Pennsylvania; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Post Operative Surgical Site Infection
Intervention: Procedure: Supplemental Perioperative Oxygen
Sponsor: Major Extremity Trauma Research Consortium
Recruiting - Condition: Not-celiac Wheat Sensitivity
Interventions: Dietary Supplement: wheat flour; Dietary Supplement: Xylose
Sponsor: University of Palermo
Recruiting - Conditions: Ovarian Cancer; Fallopian Tubes Cancer; Peritoneal Cancer
Interventions: Procedure: Secondary Cytoreductive Surgery; Drug: Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC); Drug: platinum-based systemic chemotherapy postoperatively
Sponsors: Memorial Sloan Kettering Cancer Center; Mayo Clinic; Baptist Health South Florida; Hartford HealthCare; University of Pittsburgh; University of Chicago
Recruiting - Condition: Occupational Asthma
Intervention: Other: standardized bronchial challenge test (SCL SCL • • GenaSOL ™ GenaSIC ™)
Sponsor: University Hospital, Strasbourg, France
Recruiting - Condition: Asthma
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Pompe Disease
Intervention: Biological: alglucosidase alfa
Sponsor: Genzyme, a Sanofi Company
Recruiting - Condition: Cow Milk Allergy
Intervention: Dietary Supplement: Comparison of treatment with different amino acid formulas
Sponsor: Mahidol University
Recruiting - Condition: Allergies
Intervention: Other: No Intervention
Sponsor: Stanford University
Recruiting - Conditions: Ovarian Epithelial Cancer Recurrent; Fallopian Tube Carcinoma; Primary Peritoneal Carcinoma
Interventions: Procedure: Secondary Cytoreductive Surgery; Drug: Salvage Chemotherapy
Sponsors: Shanghai Gynecologic Oncology Group; Fudan University; Zhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Sun Yat-sen University
Recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: Trimethoprim/sulfamethoxazole (TMP/SMZ); Drug: Cephalexin; Drug: Doxycycline; Other: Sodium hypochlorite
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - Condition: Type 2 Diabetes
Interventions: Drug: Acipimox; Drug: Placebo
Sponsors: University of Colorado, Denver; VA Office of Research and Development; Pfizer
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Device: Cytosponge - Brushing
Sponsors: Mayo Clinic; University of Cambridge
Recruiting - Conditions: Acute Rhinosinusitis; Allergic Rhinitis
Intervention:
Sponsor: Virginia Commonwealth University
Recruiting - Conditions: Asthma; Allergic Asthma; Non-allergic Asthma
Interventions: Dietary Supplement: Nutritional approach for asthma; Dietary Supplement: Low Caloric Shake; Biological: whole lung allergen challenge
Sponsor: The Cleveland Clinic
Recruiting - Condition: Obesity
Intervention:
Sponsors: University of Michigan; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: Acute Asthma
Interventions: Drug: Magnesium Sulfate Sandoz; Drug: Sodium Chloride , USP PPC
Sponsors: The Hospital for Sick Children; Canadian Institutes of Health Research (CIHR); Alberta Children's Hospital; St. Justine's Hospital; Children's Hospital of Eastern Ontario; Stollery Children's Hospital; The Children's Hospital of Winnipeg; Provincial Health Services Authority
Recruiting - Condition: Irritable Bowel Syndrome
Interventions: Drug: Mesalamine; Drug: Placebo
Sponsors: University of Utah; Shire Human Genetic Therapies, Inc.
Recruiting - Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH or pdC1INH
Sponsor: Pharming Technologies B.V.
Recruiting - Condition: Asthma
Interventions: Behavioral: Motivational Communication; Behavioral: Control
Sponsors: Hopital du Sacre-Coeur de Montreal; Jewish General Hospital
Recruiting - Condition: Asthma
Intervention:
Sponsors: Connecticut Children's Medical Center; UConn Health
Recruiting - Condition: Asthma
Intervention: Device: Alair system
Sponsors: Washington University School of Medicine; The Cleveland Clinic; National Jewish Health; University of Arizona; University of Chicago; Louisiana State University Health Sciences Center in New Orleans; University of Alabama at Birmingham; Creighton University
Recruiting - Condition: Atopic Dermatitis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Asthma; Allergic Rhinitis
Intervention:
Sponsors: University of British Columbia; Allergy, Genes and Environment Network (AllerGen); Networks of Centres of Excellence (NCE)
Recruiting - Conditions: Healthy Control; Localized Urothelial Carcinoma of the Renal Pelvis and Ureter; Metastatic Malignant Neoplasm in the Bone; Metastatic Malignant Neoplasm in the Soft Tissues; Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter; Recurrent Bladder Carcinoma; Recurrent Prostate Carcinoma; Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter; Stage IV Bladder Cancer; Stage IV Bladder Urothelial Carcinoma; Stage IV Prostate Cancer
Interventions: Other: Cytology Specimen Collection Procedure; Other: Laboratory Biomarker Analysis
Sponsors: University of Washington; National Cancer Institute (NCI)
Recruiting - Condition: Hereditary Angioedema (HAE)
Intervention:
Sponsor: Shire
Recruiting - Condition: Tissue Adhesions
Intervention: Other: CineMRI
Sponsor: Radboud University
Recruiting - Conditions: Autoinflammatory Syndromes; Physical Urticaria
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Piebaldism; Idiopathic Anaphylaxis; Allergy; Chronic Urticara; Angioedema
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Congenital Hyperinsulinism
Interventions: Drug: exendin-(9-39); Other: placebo
Sponsor: Diva De Leon
Recruiting - Condition: Normal Volunteer Controls
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Anaphylaxis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Acne; Actinic Keratosis; Dysplastic Nevi; Eczema; Psoriasis; Skin Cancer; Rosacea; Leg Ulcers; Foot Ulcers; Atopic Dermatitis
Intervention:
Sponsor: University of California, Davis
Recruiting - Conditions: Atopic Dermatitis; Eczema; Ichthyosis Vulgaris
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - Condition: Atopic Dermatitis
Intervention: Drug: Pimecrolimus
Sponsors: Valeant Pharmaceuticals International, Inc.; Clinical Research Computing Unit (University of Pennsylvania)
Recruiting - Conditions: Cutaneous T-cell Lymphoma; Sezary Syndrome; Mycosis Fungoides; Eczema; Atopic Dermatitis
Intervention: Other: Blood draw or skin biopsy
Sponsor: University of Pittsburgh
Recruiting - Conditions: Urticaria; Arthropathy; Lymphadenopathy; Nervous System Anomalies
Intervention:
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - Conditions: Asthma; Eosinophilia; Helminthiasis; Hypersensitivity; Parasitic Disease
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Asthma
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
Clinical Trial Locations